竹叶提取物对酪氨酸酶和黑色素瘤细胞的影响
|
摘要
为了推动我国丰富的竹叶资源的综合开发利用,本文以竹叶提取物对酪氨酸酶的影响作为评价指标,筛选高活性的竹种。采用活性追踪,利用现代色谱和波谱学手段,分析具有抑制酪氨酸酶活性的供试竹种的竹叶化学成分,分离并鉴定高活性化合物,进一步研究高活性化合物对黑色素瘤细胞的影响,为色素型皮肤病的治疗、化妆品、生物农药、食品添加剂等提供参考。主要研究结果如下:
1.竹叶提取物对酪氨酸酶活性的影响
在浓度为2g?L-1时,研究了34种竹叶提取物对酪氨酸酶的影响,发现毛环竹、翠竹、高节竹和阔叶箬竹等4种竹叶提取物对酪氨酸酶活性抑制性较强,这4种竹叶提取物和曲酸的IC50依次为: 7.88 g?L-1、6.83 g?L-1、5.24 g?L-1、4.93 g?L-1和0.08 g?L-1。
2.阔叶箬竹竹叶中抑制酪氨酸酶活性成分的分离、鉴定
通过活性追踪方法,采用波谱分析,从阔叶箬竹竹叶中分离并鉴定出对酪氨酸酶有抑制活性的化合物对羟基肉桂酸乙酯,其IC50=0.219g?L-1。分析其抑制机理,可知其抑制双酚酶是混合型抑制。
3.阔叶箬竹竹叶的化学成分分析
对具有抑制酪氨酸酶活性和经济价值较高的阔叶箬竹竹叶的化学成分进行分析,初步分离获得5种化合物包括苯甲酸、邻羟基苯甲酸、2-羟基-4-甲氧基-苯乙酮、7-羟基-4’-甲氧基-异黄酮和异鼠李素。
4.对羟基肉桂酸乙酯对黑色素瘤细胞酪氨酸酶的抑制作用
对羟基肉桂酸乙酯对黑色素瘤细胞酪氨酸酶的抑制作用测定结果表明,在添加药物24h后,从竹叶中提取的对羟基肉桂酸乙酯和化学合成的对羟基肉桂酸乙酯对酪氨酸酶的抑制差异显著,但48h和72h后,总体差异不显著。竹叶提取的对羟基肉桂酸乙酯和曲酸相比较:在添加药物24h和72h后,曲酸显著高于竹叶提取的对羟基肉桂酸乙酯;在添加药物48h后,两者差异不显著。
同一浓度下的同一种药物总体上随着给药时间延长抑制率随之增加。
给药时间相同,同一种药物随着浓度增加,抑制能力随之增强。在添加药物24h后,这三种药物对黑色素瘤细胞酪氨酸酶的抑制率较低,呈现一定的波动。给药48h后,曲酸、从竹叶提取的对羟基肉桂酸乙酯和化学合成的对羟基肉桂酸乙酯IC50分别为48.53 mg?L -1、75.75 mg?L -1和67.13 mg?L -1。给药72h后,曲酸、竹叶提取和化学合成的对羟基肉桂酸乙酯IC50分别为24.45 mg?L-1、61.95mg?L-1和56.06mg?L-1,这三种药物抑制能力从强到弱排序为:曲酸、化学合成的对羟基肉桂酸乙酯和竹叶提取的对羟基肉桂酸乙酯。随着给药时间延长,这三种药物的IC50均降低。
5对黑色素瘤细胞增殖率的影响
利用CCK-8试剂盒测定羟基肉桂酸乙酯对黑色素瘤细胞增殖的抑制率,发现在低浓度时,竹叶提取和化学合成的对羟基肉桂酸乙酯差异显著,但在高浓度时,它们差异就不显著。浓度在20mg?L-1时,曲酸显著高于化学合成的对羟基肉桂酸乙酯,但在5mg?L-1、10mg?L-1、50mg?L-1和100 mg?L-1等浓度下,两者的差异不显著。浓度在50mg?L-1和10 mg?L-1时,曲酸显著高于竹叶提取的对羟基肉桂酸乙酯,但在5mg?L-1、20mg?L-1和100mg?L-1等浓度下,两者的差异又不显著。从竹叶中提取的对羟基肉桂酸乙酯、化学合成的对羟基肉桂酸乙酯和曲酸的IC50分别为:30.262 mg?L-1、35.473 mg?L-1和19.325 mg?L-1,但它们的IC90比较接近,分别为117.51 mg?L-1、114.62 mg?L-1和115.54 mg?L-1。总体上,这三种药物在低浓度时差异显著;但在高浓度时,差异不显著。
添加竹叶提取的和化学合成的对羟基肉桂酸乙酯、曲酸均可在一定程度上干扰细胞增殖,使细胞生长受到抑制。细胞生长受抑制和受伤害程度随着药物浓度增加和时间的延长而愈加严重。
In order to promote the use of abundant bamboo resources in China, Some bamboo species with high inhibitory activity were selected through the effect of bamboo leaves extractive on the tyrosinase and some highly active compounds were seperated and identified by modern chromatography and spectroscopy. The analysis of the effect of the active compounds on the melanoma cells and the chemical composition of bamboo leaves with high inhibition will provid basic research for the treatment of skin pigment, cosmetics, biological pesticides, food additives and so on.The main results were as follows:
1. The study for the tyrosinase inhibitory activity of extracts of the 34 kinds of bamboo leaves showed that Indoealamus latifotius, Phyollostachys promlnens,Sasa pygmaea and Phyllostachys meyeri exhibited stronger inhibition on the concentration of 2 g?L-1 and the IC50 of the aboved four bamboo leaves and kojic aicd were 7.88 g?L-1,6.83 g?L-1,5.24 g?L-1,4.93g?L-1 and 0.08 g?L-1.
2. ethyl-p-hydroxycinnamate with higher inhibitory activity on tyrosinase was extracted from the leaves of Indoealamus latifotius through bioassay-guided and identified through modern spectroscopy.IC50 of ethyl-p-hydroxycinnamate was 0.22g?L-1. Ethyl-p-hydroxy- cinnamate exhibited mixed-competitive.
3. The leaves of Indoealamus latifotius with higher inhibitory activity on tyrosianse and economic value were separated and five compounds were isolated:benzoic acid, 2-Hydroxy -benzoic acid, 2'-hydroxy-4'-methoxy-acetophenon,7-hydroxy-4’-methoxy isoflavone, Isorhamnetin.
4. Effect of ethyl-p-hydroxycinnamate on the tyrosinase in melanoma cells
Comparing with the ethyl-p-hydroxycinnamate extracted from bamboo and the chemosynthetic showed significant difference after adding drugs 24h but no significant difference affter adding drugs 48h and 72h.Comparing with the ethyl-p-hydroxycinnamate extracted from bamboo and kojic acid showed kojic acid was significant higher than the ethyl-p-hydroxycinnamate affter adding drugs 24 and 72h but no significant difference affter adding drugs 48h.
The inhibition of every drug increased with the concentration and the deliver time in general.
The inhibition of every drug increased with the concentration at the same deliver time. Adding drugs 24h later, inhibitiones ratio of above three drugs of above drugs on the tyrosinase of melanoma cells were relatively low and showed fluctuated. The IC50 of kojic acid and ethyl-p-hydroxycinnamate extracted from bamboo and the chemosynthetic were 48.53 mg?L-1,75.75mg?L-1 and 67.13mg?L-1 adding drug 48h later and 24.45 mg?L-1,61.95 mg?L-1 and 56.06 mg?L-1 after adding drug 72h. The order of the inhition of three drugs was kojic acid, ethyl-p-hydroxycinnamate extracted from the chemosynthetic and bamboo. The IC50 declined with the deliver time.
5. Effect of ethyl-p-hydroxycinnamate on the appreciation rates of melanoma cells
The determination of the inhibition on melanoma cells by CCK-8 showed significant difference when the concentrationes were 5mg?L-1,10mg?L-1 and 20 mg?L-1 comparing with the ethyl-p-hydroxycinnamate extracted from bamboo and the chemosynthetic but they were on the contrary when the concentriones were 50mg?L-1and 100 mg?L-1.The inhibition was higher than the chemosynthetic ethyl-p-hydroxycinnamate when the concentration was 20mg?L-1 but they were on the contrary when the concentriones were 5mg?L-1,10 mg?L-1 and 50 mg?L-1 and 100 mg?L-1. The inhibitiones were higher than the ethyl-p-hydroxycinnamate extracted from bamboo leaves when the concentration was 50mg?L-1 and 10mg?L-1, but they were on the contrary when the concentriones were 5mg?L-1,20 mg?L-1 and100mg?L-1.IC50 of the ethyl-p- hydroxycinnamate extracted from bamboo and the chemosynthetic ethyl-p-hydroxycinnamate and kojic acid were 30.262 mg?L-1,35.473 mg?L-1and19.325 mg?L-1. IC90 of three kinds of drug were closer and they were 117.51 mg?L-1,114.62 mg?L-1and 115.54 mg?L-1. In general, comparing with the aboved three drugs showed significant difference when the concentrationes were lower but no significant difference when the concentrationes were higher.
Melanoma cells proliferation and growth were inhibited after adding ethyl-p-hydroxy- cinnamate extracted from bamboo leaves,the chemosynthetic ethyl-p-hydroxycinnamate and kojic acid and the extent of injury increased with concentration increasing and time.
1.竹叶提取物对酪氨酸酶活性的影响
在浓度为2g?L-1时,研究了34种竹叶提取物对酪氨酸酶的影响,发现毛环竹、翠竹、高节竹和阔叶箬竹等4种竹叶提取物对酪氨酸酶活性抑制性较强,这4种竹叶提取物和曲酸的IC50依次为: 7.88 g?L-1、6.83 g?L-1、5.24 g?L-1、4.93 g?L-1和0.08 g?L-1。
2.阔叶箬竹竹叶中抑制酪氨酸酶活性成分的分离、鉴定
通过活性追踪方法,采用波谱分析,从阔叶箬竹竹叶中分离并鉴定出对酪氨酸酶有抑制活性的化合物对羟基肉桂酸乙酯,其IC50=0.219g?L-1。分析其抑制机理,可知其抑制双酚酶是混合型抑制。
3.阔叶箬竹竹叶的化学成分分析
对具有抑制酪氨酸酶活性和经济价值较高的阔叶箬竹竹叶的化学成分进行分析,初步分离获得5种化合物包括苯甲酸、邻羟基苯甲酸、2-羟基-4-甲氧基-苯乙酮、7-羟基-4’-甲氧基-异黄酮和异鼠李素。
4.对羟基肉桂酸乙酯对黑色素瘤细胞酪氨酸酶的抑制作用
对羟基肉桂酸乙酯对黑色素瘤细胞酪氨酸酶的抑制作用测定结果表明,在添加药物24h后,从竹叶中提取的对羟基肉桂酸乙酯和化学合成的对羟基肉桂酸乙酯对酪氨酸酶的抑制差异显著,但48h和72h后,总体差异不显著。竹叶提取的对羟基肉桂酸乙酯和曲酸相比较:在添加药物24h和72h后,曲酸显著高于竹叶提取的对羟基肉桂酸乙酯;在添加药物48h后,两者差异不显著。
同一浓度下的同一种药物总体上随着给药时间延长抑制率随之增加。
给药时间相同,同一种药物随着浓度增加,抑制能力随之增强。在添加药物24h后,这三种药物对黑色素瘤细胞酪氨酸酶的抑制率较低,呈现一定的波动。给药48h后,曲酸、从竹叶提取的对羟基肉桂酸乙酯和化学合成的对羟基肉桂酸乙酯IC50分别为48.53 mg?L -1、75.75 mg?L -1和67.13 mg?L -1。给药72h后,曲酸、竹叶提取和化学合成的对羟基肉桂酸乙酯IC50分别为24.45 mg?L-1、61.95mg?L-1和56.06mg?L-1,这三种药物抑制能力从强到弱排序为:曲酸、化学合成的对羟基肉桂酸乙酯和竹叶提取的对羟基肉桂酸乙酯。随着给药时间延长,这三种药物的IC50均降低。
5对黑色素瘤细胞增殖率的影响
利用CCK-8试剂盒测定羟基肉桂酸乙酯对黑色素瘤细胞增殖的抑制率,发现在低浓度时,竹叶提取和化学合成的对羟基肉桂酸乙酯差异显著,但在高浓度时,它们差异就不显著。浓度在20mg?L-1时,曲酸显著高于化学合成的对羟基肉桂酸乙酯,但在5mg?L-1、10mg?L-1、50mg?L-1和100 mg?L-1等浓度下,两者的差异不显著。浓度在50mg?L-1和10 mg?L-1时,曲酸显著高于竹叶提取的对羟基肉桂酸乙酯,但在5mg?L-1、20mg?L-1和100mg?L-1等浓度下,两者的差异又不显著。从竹叶中提取的对羟基肉桂酸乙酯、化学合成的对羟基肉桂酸乙酯和曲酸的IC50分别为:30.262 mg?L-1、35.473 mg?L-1和19.325 mg?L-1,但它们的IC90比较接近,分别为117.51 mg?L-1、114.62 mg?L-1和115.54 mg?L-1。总体上,这三种药物在低浓度时差异显著;但在高浓度时,差异不显著。
添加竹叶提取的和化学合成的对羟基肉桂酸乙酯、曲酸均可在一定程度上干扰细胞增殖,使细胞生长受到抑制。细胞生长受抑制和受伤害程度随着药物浓度增加和时间的延长而愈加严重。
In order to promote the use of abundant bamboo resources in China, Some bamboo species with high inhibitory activity were selected through the effect of bamboo leaves extractive on the tyrosinase and some highly active compounds were seperated and identified by modern chromatography and spectroscopy. The analysis of the effect of the active compounds on the melanoma cells and the chemical composition of bamboo leaves with high inhibition will provid basic research for the treatment of skin pigment, cosmetics, biological pesticides, food additives and so on.The main results were as follows:
1. The study for the tyrosinase inhibitory activity of extracts of the 34 kinds of bamboo leaves showed that Indoealamus latifotius, Phyollostachys promlnens,Sasa pygmaea and Phyllostachys meyeri exhibited stronger inhibition on the concentration of 2 g?L-1 and the IC50 of the aboved four bamboo leaves and kojic aicd were 7.88 g?L-1,6.83 g?L-1,5.24 g?L-1,4.93g?L-1 and 0.08 g?L-1.
2. ethyl-p-hydroxycinnamate with higher inhibitory activity on tyrosinase was extracted from the leaves of Indoealamus latifotius through bioassay-guided and identified through modern spectroscopy.IC50 of ethyl-p-hydroxycinnamate was 0.22g?L-1. Ethyl-p-hydroxy- cinnamate exhibited mixed-competitive.
3. The leaves of Indoealamus latifotius with higher inhibitory activity on tyrosianse and economic value were separated and five compounds were isolated:benzoic acid, 2-Hydroxy -benzoic acid, 2'-hydroxy-4'-methoxy-acetophenon,7-hydroxy-4’-methoxy isoflavone, Isorhamnetin.
4. Effect of ethyl-p-hydroxycinnamate on the tyrosinase in melanoma cells
Comparing with the ethyl-p-hydroxycinnamate extracted from bamboo and the chemosynthetic showed significant difference after adding drugs 24h but no significant difference affter adding drugs 48h and 72h.Comparing with the ethyl-p-hydroxycinnamate extracted from bamboo and kojic acid showed kojic acid was significant higher than the ethyl-p-hydroxycinnamate affter adding drugs 24 and 72h but no significant difference affter adding drugs 48h.
The inhibition of every drug increased with the concentration and the deliver time in general.
The inhibition of every drug increased with the concentration at the same deliver time. Adding drugs 24h later, inhibitiones ratio of above three drugs of above drugs on the tyrosinase of melanoma cells were relatively low and showed fluctuated. The IC50 of kojic acid and ethyl-p-hydroxycinnamate extracted from bamboo and the chemosynthetic were 48.53 mg?L-1,75.75mg?L-1 and 67.13mg?L-1 adding drug 48h later and 24.45 mg?L-1,61.95 mg?L-1 and 56.06 mg?L-1 after adding drug 72h. The order of the inhition of three drugs was kojic acid, ethyl-p-hydroxycinnamate extracted from the chemosynthetic and bamboo. The IC50 declined with the deliver time.
5. Effect of ethyl-p-hydroxycinnamate on the appreciation rates of melanoma cells
The determination of the inhibition on melanoma cells by CCK-8 showed significant difference when the concentrationes were 5mg?L-1,10mg?L-1 and 20 mg?L-1 comparing with the ethyl-p-hydroxycinnamate extracted from bamboo and the chemosynthetic but they were on the contrary when the concentriones were 50mg?L-1and 100 mg?L-1.The inhibition was higher than the chemosynthetic ethyl-p-hydroxycinnamate when the concentration was 20mg?L-1 but they were on the contrary when the concentriones were 5mg?L-1,10 mg?L-1 and 50 mg?L-1 and 100 mg?L-1. The inhibitiones were higher than the ethyl-p-hydroxycinnamate extracted from bamboo leaves when the concentration was 50mg?L-1 and 10mg?L-1, but they were on the contrary when the concentriones were 5mg?L-1,20 mg?L-1 and100mg?L-1.IC50 of the ethyl-p- hydroxycinnamate extracted from bamboo and the chemosynthetic ethyl-p-hydroxycinnamate and kojic acid were 30.262 mg?L-1,35.473 mg?L-1and19.325 mg?L-1. IC90 of three kinds of drug were closer and they were 117.51 mg?L-1,114.62 mg?L-1and 115.54 mg?L-1. In general, comparing with the aboved three drugs showed significant difference when the concentrationes were lower but no significant difference when the concentrationes were higher.
Melanoma cells proliferation and growth were inhibited after adding ethyl-p-hydroxy- cinnamate extracted from bamboo leaves,the chemosynthetic ethyl-p-hydroxycinnamate and kojic acid and the extent of injury increased with concentration increasing and time.
引文
[1]傅懋毅,杨校生.我国竹类研究展望和竹林生境利用竹子研究汇刊, 2003. 22(002):1-8.
[2]陆志科,谢碧霞.竹叶化学成分的分析与资源的开发利用林业科技开发, 2003. 17(1):6-9.
[3]郭雪峰,孟志芬,熊彩云.竹子天然产物种类及其加工利用的研究世界竹藤通讯, 2006,4(002):1-4.
[4]杜孝元.酪氨酸酶活性抑制实验及其在祛斑美白化妆品功效评价中的应用中国美容医学,2005(6):740-742.
[5]李洪武,朱文元.白癜风丸及其组方中药对酪氨酸酶活性的影响中国麻风皮肤病杂志,2007(1):39-40.
[6]欧志敏.酪氨酸酶的应用研究进展中国生物工程杂志,2005(B04): 163-169.
[7]李洪武,朱文元.白术及茯苓提取物对豚鼠皮肤酪氨酸酶mRNA基因表达水平的影响.中华皮肤科杂志,2001(2):134-135.
[8] Kittlesen, D. Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development 1. The Journal of Immunology,1998,160(5): 2099-2106.
[9]李韶勇,孙命.黑色素的合成及其常见抑制剂的作用机理天津师范大学学报:自然科学版,2002(1):17-21.
[10]龚静.红景天水提液对酪氨酸酶抑制效果的初步研究四川大学学报:自然科学版, 2006(2): 468-471.
[11]韩强,林惠芬.几种中药提取物对酪氨酸酶活性的抑制香料香精化妆品,1998(4):22-24.
[12]弓晓杰.桔梗中抑制酪氨酸酶活性成分的研究中药材,2004(4): 257-259.
[13]吴皓.橘皮中的酪氨酸酶抑制剂蜜橘黄素国外医学:中医中药分册,2004(1): 51-51.
[14]王福兴,陈前进.具抑制酪氨酸酶活性祛斑增白药物中国医院药学杂志,1999(8): 479-480.
[15]陈清西,宋康康.酪氨酸酶的研究进展厦门大学学报:自然科学版,2006(5):731-737.
[16]陈清西,林建峰,宋康康.酪氨酸酶抑制剂的研究进展厦门大学学报:自然科学版,2007(2): 274-282.
[17]王寒清,王昌涛,董银卯.美白化妆品的功能评价方法日用化学品科学,2007(2):32-34.
[18]唐海谊,何冠邦,周喜林.美白中药之水及乙醇提取物对酪氨酸酶抑制功效之比较中国药学杂志,2005(5):342-343.
[19] Pomerantz, S. L-tyrosine-3, 5-3H assay for tyrosinase development in skin of newborn hamsters. 1969,10(6)838-839.
[20] Chen, Y. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proceedings of the National Academy of Sciences, 1995. 92(18): 8125-8129.
[21] Svitel. J.,S. Miertus. Development of tyrosinase-based biosensor and its application for monitoring ofbioremediation of phenol and phenolic compounds. Environ. Sci. Technol, 1998,32(6):828-832.
[22] Anh.T. Development of tyrosinase biosensor based on pH-sensitive field-effect transistors for phenols determination in water solutions. Talanta, 2002,56(4):627-634.
[23] Carralero Sanz. Development of a tyrosinase biosensor based on gold nanoparticles-modified glassy carbon electrodes Application to the measurement of a bioelectrochemical polyphenols index in wines. Analytica Chimica Acta, 2005,528(1):1-8.
[24] Dempsey E., D. Diamond, A. Collier. Development of a biosensor for endocrine disrupting compounds based on tyrosinase entrapped within a poly (thionine) film. Biosensors and Bioelectronics, 2004,20(2):367-377.
[25]徐幸莲,陈伯祥.黑色素的研究进展中国畜产与食品, 1997,4(3):135-137.
[26]肖燕,李青峰.色素研究进展中华临床医药杂志(北京),2003,4(12):45-46.
[27]赵肃清,蔡燕飞.天然黑色素的研究进展广州食品工业科技,2001,17(3): 54-55.
[28]兰风华,高磊.白癜风自身免疫机理的研究进展上海免疫学杂志,1998,18(4): 250-252.
[29]高天文,刘荣卿.恶性黑素瘤病因及病理机制研究进展实用肿瘤杂志,1998, 13(6): 323-325.
[30]杨翠红.人类黑色素瘤抗原的研究进展国外医学:免疫学分册,1998,21(2):68-71.
[31]吴品茹,刘健航.角质形成细胞在色素增加性疾病中的作用研究进展中国美容医学,2007,16(5):703-705.
[32]程东庆,尉晓冬.复方中药对小鼠b-16黑素瘤细胞株黑素合成和酪氨酸酶的激活作用中华皮肤科杂志,2000(3):173-174.
[33]邹先伟,蒋志胜.植物源酪氨酸酶抑制剂研究进展中草药,2004(6):702-705.
[34]李飞跃.竹叶主要化学成分分析及其生物活性研究现状江西林业科技,2006,4:34-36.
[35]李洪玉,孙静芸,戴诗文.竹叶化学成分研究中药材,2003,26(8):562-563.
[36]李少鹏.竹叶提取物的抗血栓作用研究中国热带医学, 2005,5(6):1202-1204.
[37]林凯.淡竹竹叶挥发油成分分析.江西农业学报,2009,21(2):92-93.
[38]陆志科,谢碧霞.竹叶活性成分分析及其提取物抗菌效果中南林学院学报, 2004, 24(4): 70-73.
[39]陆志科,谢碧霞.不同种竹叶的化学成分及其提取物抗菌活性的研究西北林学院学报, 2005,20(1):49-52.
[40]马世玉.竹叶水溶性提取液抗氧化作用的实验研究时珍国医国药,2005,16(6):472-473.
[41]马世玉.竹叶提取液抗氧化作用的实验研究.中国老年学杂志,2005,25(1):93-94.
[42]马世玉.竹叶提取液对小鼠的抗氧化作用中国临床药理学与治疗学,2004,9(5):585-587.
[43]许宝泉,吴水英,宋秋华.竹叶黄酮的生理功能研究进展江西林业科技,2006,1:37-39.
[44]周琦.竹叶提取物的抗血栓作用沈阳药科大学学报,2006,23(7):459-462.
[45]郭雪峰.用清除有机自由基DPPH法评价竹叶提取物抗氧化能力光谱学与光谱分析, 2008,28(007): 1578-1582.
[46]蒋企洲.箬竹叶黄酮对油脂的抗氧化性研究实用临床医药杂志,2008,12(4): 50-51.
[47]宋仲容.竹叶提取物的抗氧化活性研究化学研究与应用,2006,18(1):67-69.
[48]张英,丁霄霖.竹叶有效成分和抗活性氧自由基效能的研究竹子研究汇刊,1996,15(003): 17-24.
[49] Kweon. M., H. Hwang, H. Sung. Identification and antioxidant activity of novel chlorogenic acid derivatives from bamboo (Phyllostachys edulis). J. Agric. Food Chem,2001,49(10):4646-4655.
[50] Park H. Antioxidant flavone glycosides from the leaves of Sasa borealis. Archives of pharmacal research,2007,30(2):161-166.
[51]张英.竹叶黄酮的生理与药理活性世界竹藤通讯,2004,2(2):1-11.
[52] Mu J. Identification and evaluation of antioxidant activities of bamboo extracts. Forestry Studies in China, 2004, 6(2):1-5.
[53] Xue-feng GUO. Detection of Antioxidative Capacity of Bamboo Leaf Extract by Scavenging Organic Free Radical DPPH. Spectroscopy and Spectral Analysis, 2008,28 (07): 1578-1582
[54] Zhang Y.,X. Ding. The bio-antioxidative activity of functional factors in bamboo leaves, Wiley,2005[J]
[55] Zhang Y. Isolation and purification of four flavone C-glycosides from antioxidant of bamboo leaves by macroporous resin column chromatography and preparative high-performance liquid chromatography. Food Chemistry, 2008. 107(3): 1326-1336.
[56] Zhang Y., X.Q. Wu. Comparison study on total flavonoid content and anti-free redical activity of the leaves of bamboo, phyllostachys nigra, and Ginkgo bilabo. Zhongguo Zhong Yao Za Zhi, 2002. 27(4): 254-7.
[57]孙长花,张素华,张凌云.竹叶黄酮的生理活性与应用研究四川食品与发酵,2006,42(1): 13-16.
[58]吴三林,李书华,弓加文.竹叶活性成分的研究进展乐山师范学院学报, 2005. 20(5): 53-54.
[59]高志强,江相兰,宋仲容.竹叶中黄酮类化合物的研究进展评述西南民族大学学报:自然科学版,2005. 31(1):38-43.
[60]支崇远.玉米花粉黄酮类物质对SD大鼠降血脂作用的研究放射免疫学杂志,2002. 6.
[61]张洪坤.竹叶的保健功能及应用山东商业职业技术学院学报, 2005. 5(002):91-94.
[62]张英,陆柏益,吴晓琴.竹叶黄酮的心脑血管药理活性研究中国食品添加剂,2005,C00:59-66.
[63]王谦.竹文化与竹康宁世界竹藤通讯,2004,2(002):26-30.
[64]袁秀英,心脑血管病的预防与竹康宁世界竹藤通讯,2004,2(002):12-16.
[65]陆柏益,张英,吴晓琴.竹叶黄酮的抗氧化性及其心脑血管药理活性研究进展林产化学与工业, 2005. 25(3):120-124.
[66]杨抚林.竹叶提取物中功能性成分及效用中国食物与营养,2004,(005):53-55.
[67]张佐玉,张喜.竹子在中医药和保健品开发中的潜力世界科学技术:中药现代化,2000,2(003):54-56.
[68]黄占旺,邹双双,熊水波.毛竹叶提取物抑菌作用的初步研究江西农业大学学报, 2005, 27(006):960-963.
[69]岳永德,操海群,汤锋.竹提取物的化学成分及其利用研究进展安徽农业大学学报,2007,34(003):328-333.
[70]谢碧霞,陆志科.麻竹叶抑菌活性成分的分离鉴定中南林学院学报,2005,25(005):10-14.
[71]许丽旋,蔡建秀.竹笋壳黄酮提取液抑菌效应初步研究世界竹藤通讯,2006,4(004):29-31.
[72]蔡建秀.竹笋壳黄酮提取液抑菌效应初步研究世界竹藤通讯,2006(04).
[73]黄亚利,操海群.毛竹叶提取物不同流份抑菌活性评价安徽农学通报, 2008,14(14): 108-109.
[74]黄文,王益.竹叶的化学成份及应用进展中国林副特产,2002,(003):65-66.
[75]丁玉强,陈春英.箬叶水溶性多糖的色谱研究色谱, 1996,14(006):470-472.
[76]姚旌旗,李映红.竹叶提取液对ASP-Ⅰ肺癌细胞生长的影响咸宁医学院学报, 2002,16(001): 21-22.
[77]江庆中,刘景致.箬竹酒研究江西林业科技,1999(002):14-15.
[78]刘翠,王文久.竹叶资源研究进展及开发利用:兼谈云南丛生竹竹叶资源开发对策林业建设,1999(006):10-14.
[79]吕兆林.毛竹叶挥发油的提取方法北京林业大学学报, 2008. 30(4): 135-140.
[80]毛燕,刘志坤.毛竹叶挥发性成分的提取与GC-MS分析福建林学院学报,2001,21(003): 265-267.
[81]王学利,毛燕.箬竹叶挥发性成分GC-MS分析竹子研究汇刊,2001,20(002): 36-38.
[82]张英,汤坚.竹叶精油和头香的OGC-MS-DS研究天然产物研究与开发, 1998,10(004): 38-44.
[83]高丽欣.慈竹叶精油化学成分研究天然产物研究与开发,2002,14:(06)35-40.
[84]廖威.毛竹叶化学成分的初步测定山西大学学报(自然科学版), 2003,26:(01)46-48.
[85]张英,唐莉莉.竹叶功能因子生物抗氧化性质的研究营养学报,1998,20(003):367-371.
[86]郝培应,徐有明,皮忠来.竹类植物衍生物的生理活性及其疗效的研究进展世界林业研究, 2004,17(003): 21-24.
[87]莫开菊,张中利.竹叶提取物对微生物抑制作用研究湖北民族学院学报:自然科学版, 2000,18(004): 16-18.
[88]郝培应,肖家军,齐笑笑.紫竹叶提取物的抑菌效果研究安徽农业科学, 2008,36(7): 2810-2812.
[89]操海群,岳永德.竹提取物对玉米蟓Sitophilus zeamais Motsch生物活性的初步研究.农药学学报,2002,4(001):80-84.
[90]操海群.竹提取物对蚜虫生物活性的研究植物保护,2003,29(002):33-36.
[91]张英.天然功能性竹叶提取物-竹叶黄酮中国食品添加剂,2002,(003):54-58.
[92] Lu B. Toxicology and safety of anti-oxidant of bamboo leaves. Part 1: Acute and subchronic toxicitystudies on anti-oxidant of bamboo leaves. Food and chemical toxicology, 2005,43(5): 783-792.
[93]王腾凤.竹叶提取物及其在口腔护理中的应用.牙膏工业,2005,(003):15-17.
[94] Chikako Masuoka, M.O., Yasuyuki ITO,Toshihiro Nohara. Antioxidative, Antihyaluronidase and Antityrosinase Activities of Some Constituents from the Aerial Part of Piper elongatum VAHL. Food Sci. Technol. Res.,2003. 9(2):197–201.
[95] Lerner, A. Mammalian tyrosinase: the relationship of copper to enzymatic activity. Journal of Biological Chemistry,1950. 187(2):793-802.
[96]曲娜,郁铭.酪氨酸酶活性中心模型化合物的合成与表征天津师范大学学报:自然科学版, 2003(1):17-19.
[97] Masamoto, Y. Mushroom Tyrosinase Inhibitory Activity of Esculetin Isolated from Seeds of Euphorbia lathyris L. Bioscience, Biotechnology, and Biochemistry, 2003, 67(3):631-634.
[98] Te-Sheng Chang, H.-Y.D., Hang-ching Lin, Identifying 6,7,4'-Trihydroxyisoflavone as a potent tyrosinase inhibitor. Biosci. Biotechnol. Biochem., 2005,69(10):1999-2001.
[99]雷铁池.酪氨酸酶基因家族与皮肤黑素生成.国外医学:皮肤性病学分册,1998(2):81-85.
[100]杨舒黎,毛华明.酪氨酸酶基因研究进展动物科学与动物医学,2003,(9):22-23.
[101]元建鹏.酪氨酸酶基因在hek293细胞表达的mri评价中国病理生理杂志,2003,(9): 1210-1213.
[102]元建鹏,梁碧玲.酪氨酸酶基因在HepG2细胞中表达的MR评价及其方法.癌症,2003,22(2):156-159.
[103]李春英,高天文.酪氨酸酶相关蛋白-1的基因克隆表达及纯化中国皮肤性病学杂志,2001,15(6):368-370.
[104]赵会全,刘望夷.酷氨酸酶的分子生物学研究进展国外医学:分子生物学分册,1991,13(006):273-275.
[105] Kawabata T. Molecular cloning of insect pro-phenol oxidase:a copper-containing protein homologous to arthropod hemocyanin. Proceedings of the National Academy of Sciences, 1995,92(17): 7774-7778.
[106] Orlow S. High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: Evidence for a melanogenic complex. Journal of Investigative Dermatology,1994,103(2):196-201.
[107] Jackson. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. The EMBO Journal,1992,11(2):527.
[108] Vijayasaradhi S. Melanocyte differentiation marker gp75, the brown locus protein, can be regulated independently of tyrosinase and pigmentation. Journal of Investigative Dermatology,1995,105(1): 113-119.
[109] Hume A. Rab27a regulates the peripheral distribution of melanosomes in melanocytes. Journal of Cell Biology,2001,152(4):795-808.
[110] Jimbow K. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins inthe initial stage of melanosome biogenesis.Pigment Cell Res,2000,13(4):222-229.
[111] Casella L. Hemocyanin and tyrosinase models. Synthesis, azide binding, and electrochemistry of dinuclear copper (II) complexes with poly (benzimidazole) ligands modeling the met forms of the proteins. Inorganic Chemistry, 1993, 32(10):2056-2067.
[112] Ross,E. Solomon.An electronic structural comparison of copper-peroxide complexes of relevance to hemocyanin and tyrosinase active sites. Journal of the American Chemical Society, 1991,113(9): 3246-3259.
[113] Rompel A. Purification and spectroscopic studies on catechol oxidases from Lycopus europaeus and Populus nigra: evidence for a dinuclear copper center of type 3 and spectroscopic similarities to tyrosinase and hemocyanin. Journal of Biological Inorganic Chemistry, 1999,4(1):56-63.
[114] Baldwin M. Spectroscopic and theoretical studies of an end-on peroxide-bridged coupled binuclear copper (II) model complex of relevance to the active sites in hemocyanin and tyrosinase. Journal of the American Chemical Society, 1991,113(23):8671-8679.
[115] Pate J. Spectroscopic studies of the charge transfer and vibrational features of binuclear copper (II) azide complexes: comparison to the coupled binuclear copper active site in met azide hemocyanin and tyrosinase. Journal of the American Chemical Society, 1989,111(14):5198-5209.
[116] Decker H. , F. Tuczek. Tyrosinase catecholoxidase activity of hemocyanins: structural basis and molecular mechanism. Trends in Biochemical Sciences, 2000,25(8):392-397.
[117] Spritz R. Mutational Analysis of Copper Binding by Human Tyrosinase. Journal of Investigative Dermatology, 1997,109(2):207-212.
[118]王戈林,宁华.酪氨酸酶基因工程菌产黑色素的发酵条件研究中国医药工业杂志, 1999,(4): 150-154.
[119]曹广文,崔龙.酪氨酸酶启动子调控的cd基因治疗恶性黑色素瘤第二军医大学学报, 1998(3): 205-208.
[120]杨如义,郑能武.酪氨酸酶同功酶的抑制作用研究中国科学技术大学学报, 2000(4): 492-499.
[121]王秋枫.酪氨酸酶相关蛋白家族中国美容医学,2003(1):100-103.
[122] Lerro K.,G. Prestwich. Cloning and sequencing of a cDNA for the hemolymph juvenile hormone binding protein of larval Manduca sexta. Journal of Biological Chemistry,1990,265(32):19800-19806.
[123] Hall M. Proenzyme of Manduca sexta phenol oxidase: purification, activation, substrate specificity of the active enzyme, and molecular cloning. Proceedings of the National Academy of Sciences, 1995,92(17): 7764-7768.
[124] Kramer K. Oxidative conjugation of catechols with proteins in insect skeletal systems. Tetrahedron, 2001,57(2): 385-392.
[125] Dittmer N. Characterization of cDNAs encoding putative laccase-like multicopper oxidases and developmental expression in the tobacco hornworm, Manduca sexta, and the malaria mosquito,Anopheles gambiae. Insect biochemistry and molecular biology,2004,34(1):29-41.
[126] Morris S.,W. Muir. Dinucleotide repeat polymorphism at the human tyrosinase gene. Nucleic acids research,1991,19(24):6968.
[127] Bouchard B.. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. Journal of Experimental Medicine,1989,169(6):2029-2042.
[128] Takase M.. Cloning and sequencing of the cDNA encoding tyrosinase of the Japanese pond frog, Rana nigromaculata. Gene, 1992,121(2):359.
[129] Kwon T.. Purification and characterization of prophenoloxidase from the hemolymph of coleopteran insect, Holotrichia diomphalia larvae. Molecules and Cells (Korea Republic),1997,7(1):90-97.
[130] Bernan V.. The nucleotide sequence of the tyrosinase gene from Streptomyces antibioticus and characterization of the gene product. Gene(Amsterdam), 1985, 37(1-3):101-110.
[131] Somkuti G.,D. Solaiman,D. Steinberg. Cloning of a tyrosinase gene in Streptococcus thermophilus. Biotechnology Letters, 1993,15(8):773-778.
[132] Lee, Y. A trans-acting gene is required for the phenotypic expression of a tyrosinase gene in Streptomyces. Gene, 1988,65(1):65-71.
[133] Lee M. ,J. Anstee. Phenoloxidase and Its Zymogen from the Haemolymph of Larvae of the Lepidopteran Spodoptera Littoralis (Lepidoptera: Noctuidae). Comparative biochemistry and physiology. Part B. Biochemistry & molecular biology,1995,110(2):379-384.
[134] Ikeda K. Cloning and sequence analysis of the highly expressed melanin-synthesizing gene operon from Streptomyces castaneoglobisporus. Applied microbiology and biotechnology,1996,45(1):80-85.
[135] Kawamoto S., M. Nakamura, S. Yashima. Cloning, Sequence and Expressin of the Tyrosinase Gene from Streptomyces lavendulae MA406 A-1. Journal of fermentation and bioengineering,1993,76(5):345-355.
[136] Zhao H.. Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a TRP-1-deficient melanoma cell line. Journal of Investigative Dermatology,1996,106(4):744-752.
[137] Hasselmann D. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Am Assoc Clin Chem,2001,47:1488-1489.
[138] Tan Cheng, Zhu Wenyuan, LU Yan. Aloin,cinnamic acid and sophorarpidine are potent inhibitiors of tyrosinase. Chinese Medical Jounal,2002,115(12):1859-1862.
[139] Bin Wu. Complex Sesquiterpenoids with Tyrosinase Inhibitory Activity from the Leaves of Chloranthus tianmushanensis. American Chemical Society and American Society of Pharmacognosy,2008,71(5):877-880
[140] Zhen Yang ,Ya-Jun Yue, Miao Xing. Tyrosinase activity in ionic liquids. Biotechnol Lett,2008,30:153-158.
[141] Zong-Ping Zheng. Tyrosinase inhibitors from paper mulberry. Food Chemistry. 2008,106:529-535.
[142]李玲,宋伟民,周华. 4种美白剂对b-16细胞内酪氨酸酶活性抑制的研究.宁夏医学院学报, 2006,(1): 10-12.
[143] Kejun C., C. Jing, L. Gao. Taxiphyllin:A Cyanogenic Glucoside with Tyrosinase Inhibitory Activity from the Shoots of Pleioblastus amarus. Natural Product and Development, 2005,17(6):733-742.
[144]涂彩霞. 6味中药乙醇提取物对B16黑素瘤细胞酪氨酸酶及其相关蛋白-1、-2 mRNA表达的影响.中华皮肤科杂志, 2007(2):104-106.
[145]任冰如,吴菊兰. 6种植物提取物对酪氨酸酶活性的影响植物资源与环境学报,2003(1):58-59.
[146]王建华,雷帆. 10种中药对酪氨酸酶激活作用的研究中国中医药信息杂志,2000,(4):40-40.
[147]闫军. 14味中药对酪氨酸酶抑制作用的探讨.中国药房,2003(7):442-443.
[148]杨柳依. 14种中药提取成分对酪氨酸酶活性的抑制作用中华皮肤科杂志,2003,(4):207-209.
[149]杨景冲,王晓岚,金坚.滨海白首乌提取物对酪氨酸酶活力的影响天然产物研究与开发,2007,(5): 753-756.
[150]邰晓曦,孙婧,邓湘庆.薄荷中乌发组分的初步探索广东化工,2007,(4):45-46,62.
[151]徐建国.尚靖.补骨脂对酪氨酸酶的激活作用中草药,1991(4):168-169.
[152]王锡元,王建新.补骨脂素复配物对酪氨酸酶协同激活性能研究天然产物研究与开发, 2007(1):77-80.
[153]戴新荣,董丽敏,张验军. 2,4,6,4'-四羟基脱氧安息香的合成及其抑制酪氨酸酶活性的研究香料香精化妆品,2007,(3):7-9.
[154]张丽娟. 3-羟基苯甲酸对酪氨酸酶的抑制作用和抑菌作用厦门大学学报:自然科学版,2006,(5):705-708.
[155] Sang Yoon CHOI, S. K. Hocheol KIM. (4-Methoxy-benzylidene) -(3-methoxy-phenyl)-amine, a Nitrogen Analog of Stilbene as a Potent Inhibitor of Melanin Production. Chem. Pharm. Bull., 2002,50(4):450-452.
[156] Pierre C. Antimelanogenic Activity of 3,4-Dihydroxyacetophenone Inhibition of Tyrosinase and MITF. biosci. Biotechnol. Biochem., 2006,70(2):532-534.
[157] Derivatives K.,Keloa T. Antimicrobial and Tyrosinase Inhibitory Activities of 6-[ ( 8Z )-8-Pentadecenyl]salicylic Acid Derivatives. Journal of OLEO Science,2002,51(10):637-642.
[158] Duck Hee KIM, J.-S.H., Heung Soo BAEK. Development of 5-[(3-Aminopropyl) phosphinooxy]-2-(hydroxymethyl)-4Hpyran-4-one as a Novel Whitening Agent. Chem. Pharm. Bull., 2003,51(2):113-116.
[159] Chien, C. C. Effects on Tyrosinase Activity by the Extracts of Ganoderma lucidum and Related Mushrooms. Mycopathologia, 2008. 166(2):117-120.
[160] Yun-Hee CHANG. a Minhwan JUNG, Inhibition of Melanogenesis by Selina-4(14),7(11)-dien-8-one Isolated from Atractylodis Rhizoma Alba. Biol. Pharm. Bull,2007,30(4):719-723.
[161] Sang Keun HA, Kunho LEE. Inhibition of Tyrosinase Activity by N,N-Unsubstituted SelenoureaDerivatives. Biol. Pharm. Bull, 2005,28(5):838-840.
[162] Kyung-Hee PARK, Hwa-Sun HAHN. Inhibitory Effect of Ammonium tetrathiotungstate on Tyrosinase and Its Kinetic Mechanism. Chem. Pharm. Bull.,2006,54(9):1266-1270.
[163]龚盛昭,程江,杨卓如. Inhibitory Effect of Ferulic Acid on Oxidation of L-DOPA Catalyzed by Mushroom Tyrosinase.中国化学工程学报:英文版,2005(6):771-775.
[164] Szu-Hsiu LIU, I-Ming CHU. Inhibitory Effect of p-Hydroxybenzyl Alcohol on Tyrosinase Activity and Melanogenesis. Biol. Pharm. Bull,2007,30(6):1135-1139.
[165] Likhitwitayawuid K. , B. Sritularak. A new dimeric stilbene with tyrosinase inhibitory activity from Artocarpus gomezianus. J. Nat. Prod., 2001,64 (11), 1457–1459
[166] DaiRongYuan. Ortho-Hydroxylation of Phenol by Tyrosinase Model Compounds.中国化学快报:英文版, 2005,(2):147-150.
[167]程科军. Taxiphyllin:苦竹笋中具有酪氨酸酶抑制活性的氰苷天然产物研究与开发,2005(6):733-735,772.
[168] Kubo I., I. Kinst-Hori, Y. Yokokawa. Tyrosinase Inhibitors from Anacardium occidentale Fruits. Journal of Natural Products, 1994,57(4):545-551.
[169] Kubo I., Y. Yokokawa, I. Kinst-Hori. Tyrosinase Inhibitors from Bolivian Medicinal Plants. Journal of Natural Products, 1995,58(5):739-743.
[170] Firoza Khanom H.K.,K.T. Tyrosinase Inhibitory Activity of Bangladeshi Indigenous Mediacal Plants. Biosci. Biotechnol. Biochem.,2000,64(9):1967-1969. 171 Gandia-Herrero. Tyrosinase Inhibitory Activity of Cucumber Compounds: Enzymes Responsible for Browning in Cucumber. Journal of Agricultural and Food Chemistry, 2003,51(26):7764-7769.
[172] Soo Jin KIM, K.H.S., Hyun Wook Chang. Tyrosinase Inhibitory Prenylated Flavonoids from Sophora flavescens. Biol. Pharm. Bull.,2003,26(9):1348-1350.
[173] Xiang Lan PIAO, Man Ki PARK. Tyrosinase-Inhibitory Furanocoumarin from Angelica dahurica. Biol. Pharm. Bull.,2004,27(7):1144-1146.
[174] Sher Bahadar KHAN A., Nighat AFZA. Tyrosinase-Inhibitory Long-Chain Esters from Amberboa ramosa. Chem. Pharm. Bull.,2005,53(1):86-89.
[175]乔薇.苯甲醛及其类似物对酪氨酸酶抑制作用的研究中山大学学报:自然科学版, 2007,(5):41-44.
[176]黄璜,刘晓丹.苯甲醛族化合物抑制蘑菇酪氨酸酶活力的研究厦门大学学报:自然科学版, 2003,(1):97-101.
[177]刘晓丹,黄璜.苯甲酸对蘑菇酪氨酸酶抑制作用机理的研究厦门大学学报:自然科学版, 2003,(1):102-106.
[178]曾伟成and郑能武,苯甲酸钠对酪氨酸酶的抑制作用数理医药学杂志,2000,(2):161-161.
[179]赵荧,郑玉娟.对羟基苯甲酸对酪氨酸酶的抑制作用吉林大学自然科学学报,1998,(4): 89-90.
[180]龚盛昭,邓相庆,李仕梅.对羟基肉桂酸抑制酪氨酸酶活性的动力学研究日用化学工业, 2006(3):159-162.
[181]王勤.对氰基苯酚对蘑菇酪氨酸酶的抑制作用厦门大学学报:自然科学版, 2004,(4):568-571.
[182]黄浩.对醛基苯甲酸对蘑菇酪氨酸酶的抑制作用厦门大学学报:自然科学版,2005(4): 566-568.
[183]徐亮.酪氨酸酶催化的3,4二羟基苯基丙氨酸氧化反应的动力学分析四川大学学报:自然科学版,2005,(6):1271-1273.
[184]徐迪.酪氨酸酶催化对位取代苯酚和芳香胺的反应及其意义有机化学,2003(7):724-727.
[185]曾伟成,朱道清.酪氨酸酶催化反应机理的动力学分析数理医药学杂志,1999(2):158-158.
[186]徐迪,马林.酪氨酸酶催化氧化羟基吡啶类化合物的反应研究中山大学学报:自然科学版, 2002(6):33-35.
[187]李新荣,韩红.酪氨酸酶的酶学动力学研究南京铁道医学院学报,1992,11(1):33-36.
[188] Xue C.B. 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors. Bioorganic & Medicinal Chemistry, 2007,15(5):2006-2015.
[189] Xue C.B. Quantitative structure–activity relationship studies of mushroom tyrosinase inhibitors. Journal of Computer-Aided Molecular Design, 2008,22(5):299-309.
[190]路红星.发酵法制曲酸的研究应用四川食品与发酵,2001,(3):17-22.
[191]张廷红,葛长海,万海清.酪氮酸酶的应用研究进展沿海企业与科技,2005,(2):161-163.
[192]段玉清,刘睿,谢笔钧.莲房原花青素对酪氨酸酶活力和黑色素生物合成影响的初步研究食品科学, 2004,25(3): 169-174.
[193]操海群.竹提取物对棉铃虫幼虫及菜青虫的拒食活性昆虫知识,2005,42(2):171-174.
[194]操海群.竹提取物对棉铃虫幼虫体内几种酶系活性的影响林业科学,2006,42(7): 145-148.
[195]谢桂英,罗万春.天然源化合物曲酸对小菜蛾酚氧化酶抑制作用研究初报农药学学报,2003(001):68-72.
[196] Reinhold U. The Analysis of Tyrosinase-Specific mRNA in Blood Samples of Melanoma Patients by RT-PCR Is Not a Useful Test for Metastic Tumor Progression. Journal of Investigative Dermatology,1997,108(2):166-169.
[197] Lewis J. Evaluation of CD8+ T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. International Journal of Cancer, 2000,87:(3)114-119.
[198] Korner A. ,J. Pawelek. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science, 1982,217(4565):1163-1165.
[199] Spagnoli G. Peptide-specific CTL in tumor-infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes:a study in an unselected group of HLA-A2. 1-positive patients. International Journal of Cancer, 1995. 64(5).
[200]伍革民,彭光旭.动物黑色素研究进展甘肃畜牧兽医,2005,35(1):39-41.
[201]乌新春,段晰所.恶性黑色素瘤的研究进展承德医学院学报, 2008, 25(3): 309-312.
[202]廖贵清.恶性黑色素瘤治疗的研究进展国外医学:口腔医学分册, 1994,21(2): 83-85.
[203]刘亚玲.恶性黑素瘤治疗进展河北医科大学学报,2006,27(5):506-509.
[204]舒文,毛华明.黑色素的研究进展国外畜牧学:猪与禽,2003,2:31-34.
[205]谭玉文.神经黑色素的研究进展中国畜牧兽医,2008. 35(7):52-55.
[206]李文,邓卫东,毛华明.乌骨绵羊和黑色素的研究进展家畜生态学报,2007,28(3):1-5.
[207] Kameyama K. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. Journal of Investigative Dermatology, 1993,100(2):126-131.
[208]刘甲斐,仇雪梅.黑色素及其相关基因的研究进展生物技术通报,2007,4:55-58.
[209]钱海利,林晨.黑色素瘤分化相关基因-7研究进展国外医学:肿瘤学分册,2004. 31(2): 87-89.
[210]李春英,高天文.恶性黑色素瘤基因研究新进展实用肿瘤杂志,1998,13(6):321-322.
[211] Hussussian C. Germline p16 mutations in familial melanoma. Nature genetics, 1994, 8(1): 15-21.
[212] Metharom K. Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma. Human gene therapy, 2001,12(18):2203-2213.
[213] Spencer J. The Ca2+ Binding Capacity of Epidermal Furin Is Disrupted by H2O2-Mediated Oxidation in Vitiligo. Endocrinology, 2008, 149(4):1638.
[214] Shaker O.,S. El-Tahlawi. Is there a relationship between homocysteine and vitiligo? A pilot study. British Journal of Dermatology, 2008,159(3):720.
[215] Gavalas N. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Experimental Dermatology, 2009. 4:(5)119-124
[216] SMITH S.,B. Zhou,S. ORLOW. Expression of Tyrosinase and the Tyrosinase Related Proteins in theMitfvit (Vitiligo) Mouse Eye: Implications for the Function of the Microphthalmia Transcription Factor (Mitf). Experimental eye research,1998,66(4):403-410.
[217] Okamoto T. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. Journal of Investigative Dermatology, 1998,111(6): 1034-1039.
[218] Jimbow K. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. British Journal of Dermatology, 2001. 144(1): 55.
[219]张琳西,王臻.中波紫外线对体外培养的人黑色素细胞的影响中国美容医学, 2001,10(003):180-182.
[220]SONG Y.The role of tyrosinase in autoimmune vitiligo. Lancet(British edition),1994,344 (8929):1049-1052.
[221] Kemp E. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. Journal of Investigative Dermatology, 1997. 109(1):69-73.
[222] Kemp, E., et al., Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. British Journal of Dermatology, 1998,139(5):798.
[223] Gottumukkala R. Function-blocking autoantibodies to the melanin concentrating hormone receptor in vitiligo patients. Laboratory Investigation,2006,86(8):781-789.
[224] Stierner U. UVB irradiation induces melanocyte increase in both exposed and shielded human skin. Journal of Investigative Dermatology, 1989,92(4):561-564.
[225] Ramirez-Bosca, A., et al., Effect of the dose of ultraviolet radiation on the pigment formation by human melanocytes in vitro. Archives of Dermatological Research, 1992, 284(6):358-362.
[226] LIBOW, L., S. SCHEIDE, and V. DeLeo, Ultraviolet radiation acts as an independent mitogen for normal human melanocytes in culture. Pigment Cell Research, 1988,1(6):397-401.
[227] DUVAL C., M. REGNIER, R. SCHMIDT. Distinct Melanogenic Response of Human Melanocytes in Mono-culture, in Co-Culture with Keratinocytes and in Reconstructed Epidermis, to UV Exposure. Pigment Cell Research, 2001,14(5):348.
[228] Gilchrest B. Mechanisms of ultraviolet light-induced pigmentation. Photochemistry and photobiology,1996,63(1):1-10.
[229] Neil S. Stimulation of the adenylate cyclase of a B16 melanoma cell line by pro-opiocortin-related peptides-A structure-activity study. Regulatory Peptides, 1981,2(3):193-200.
[230] Sato H. The Expression of Corticotropin-Releasing Hormone in Melanoma. Pigment Cell Research, 2002,15(2):98.
[231] Hunt G. Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. 1994,107(1):205-211.
[232] Schith H. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. European journal of pharmacology, 1997,319(2-3):369-373.
[233] Schioth, H., R. Muceniece, and J. Wikberg, Characterisation of the melanocortin 4 receptor by radioligand binding. Pharmacology & toxicology, 1996,79(3):161.
[234]杨柳,吕荣锋.黑素细胞刺激素在不同实验动物表皮中的表达及意义浙江中医药大学学报,2008,32(1):27-29.
[235] SCHALLREUTER K -MSH can control the essential cofactor 6-tetrahydrobiopterin in melanogenesis. Annals of the New York Academy of Sciences,1999,885(1):329-341.
[236] Hunt G. Nle4DPhe7&agr ; -Melanocyte-Stimulating Hormone Increases the Eumelanin :Phaeomelanin Ratio in Cultured Human Melanocytes. Journal of Investigative Dermatology, 1995,104(1): 83-85.
[237] Wakamatsu K. Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Research, 1997,10(5):288-297.
[238]薛春雨. -MSH和MC-1R对表皮黑素细胞的调控作用实用美容整形外科杂志, 2003, 14(005):263-265.
[239]饶燕,刁庆春,王祝君.白癜风综合治疗疗效观察中华实用医药杂志, 2006. 6(23).
[240] Loir, B., et al., -Melanotropin immunoreactivity in human melanoma exudate is related to necrosis. European Journal of Cancer,1998,34(3):424-426.
[241] Wong W.,R. Minchin. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, d-Phe7] -MSH in B16 melanoma cells. International Journal of Biochemistry and Cell Biology, 1996, 28(11):1223-1232.
[242] Slominski A. Identification ofβ-endorphin, -MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Experimental Dermatology.1998,7(4):213-216.
[243] Smalley K.,T. Eisen. The involvement of p38 mitogen-activated protein kinase in the -melanocyte stimulating hormone ( -MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS letters.2000,476(3):198-202.
[244] Ghanem G . Evidence for alpha-melanocyte-stimulating hormone ( -MSH) receptors on human malignant melanoma cells. International Journal of Cancer, 1988. 41(2):248-255.
[245] Scott G.,L. Cassidy. Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model. Journal of Investigative Dermatology, 1998,111(2): 243-250.
[246] Siegrist W. Radioreceptor Assay for ;-Msh Using Mouse B16 Melanoma Cells. Journal of Receptors and Signal Transduction, 1988, 8(1-4):323-343.
[247] Abdel-Malek Z. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.2001,114(5):1019-1024.
[248] Siegrist W. Interactions of -melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. Journal of Receptors and Signal Transduction,1997,17(1):75-98.
[249] Siegrist, W., et al., Agouti Protein Inhibits Growth of B16 Melanoma Cellsin Vitroby Acting through Melanocortin Receptors. Biochemical and Biophysical Research Communications, 1996,218(1): 171-175.
[250] Blanchard, S., et al., Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. Biochemistry, 1995,34(33):10406-10411.
[251] Voisey J.,G. Kelly,D. VAN. Agouti Signal Protein Regulation in Human Melanoma Cells. Pigment Cell Research,2003,16(1):65-71.
[252] Kanetsky K. A polymorphism in the agouti signaling protein gene is associated with human pigmentation. The American Journal of Human Genetics, 2002,70(3):770-775.
[253] Valverde C. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Human molecular genetics,1996,5(10):1663-1666.
[254] Lázár-Molnár E. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine,2000,12(6):547-554.
[255] Das K., A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends in immunology,2001,22(3):130-136.
[256] Seiberg M. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Experimental Cell Research, 2000,254(1):25-32.
[257] Buchdunger E. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. Journal of Pharmacology and Experimental Therapeutics, 2000,295(1):139-145.
[258] Berking C. Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. 2004,14:(6)807-811.
[259] Mattei S. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. International Journal of Cancer, 1994,56(6)853-857.
[260] Grabbe, J., et al., Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Archives of Dermatological Research, 1994,287(1):78-84.
[261] McGill, G. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell, 2002,109(6):707-718.
[262] Mackensen A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. International Journal of Cancer, 2000,86(3):64-72
[263] Huang, S. Enforced C-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene,1996,13(11): 2339-2347.
[264] Hopkins S., N. Rothwell. Cytokines and the nervous system I: expression and recognition. Trends in Neurosciences,1995,18(2):83-88.
[265] Kanik A., M. Yaar, J. Bhawan. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. Journal of cutaneous pathology,1996,23(3):205-210.
[266] Satyamoorthy K. Constitutive Mitogen-activated Protein Kinase Activation in Melanoma Is Mediated by Both BRAF Mutations and Autocrine Growth Factor Stimulation 2003,(9)756-759.
[267]陈永红.曲酸对动物的毒性研究及安全性评价食品科学,2007:09.
[268]赖椿根,马聿桓.箬竹叶水提取物化学成分研究浙江林学院学报,1995.12(002): 161-165.
[269] PatraA G., Sengupta P. K. Carbon 213 NMR spectral studies on chalcones and acetophenone. MagnReson Chem.,1987(25):734-742.
[270]于德泉,杨俊山.《分析化学手册(第七分册)-核磁共振波谱分析第一版》,化学工业出版社,1999
[271]章晓宁.无锡市市售酱腌菜、蜜饯中苯甲酸、山梨酸、糖精钠监测结果.职业与健康, 2007,23(15):1316-1317.
[272]依凡林.皮肤美白剂的比较日用化学品科学,1999,(006):13-14.
[273]宦萍.美白祛斑与安全中国检验检疫,2003,(007):56-57.
[274]邓瑞春,章金刚.驱虫斑鸠菊对B-16黑素瘤细胞酪氨酸酶活性及黑素生成影响氨基酸和生物资源,2002,24(001):31-34.
[275]艾文胜.箬竹丰产栽培及高效利用湖南林业科技,2004,31(004):15-17.
[276]陆志科,谢碧霞.竹叶化学成分的分析与资源的开发利用林业科技开发,2003,17(001): 6-9.
[277] Pieterse C. Systemic resistance in Arabidopsis induced by biocontrol bacteria is independent of salicylic acid accumulation and pathogenesis-related gene expression. The Plant Cell Online, 1996, 8(8):1225-1237.
[278]仲岳桐.高油脂食品中苯甲酸,山梨酸,糖精钠样品前处理的方法改进中国卫生检验杂志, 2001,11(004):471-471.
[279]郑国兴,张春乐,黄浩.水杨酸的抑酶与抑菌作用厦门大学学报自然科学版,2006,45(B05):19-22.
[280]朱恒英,陈永培.油茶饼中油茶皂甙体外抑菌试验福建中医药,1989,20(002):44-45.
[281]陈小红.水杨酸在银屑病治疗中的作用国外医学:皮肤性病学分册,2000,26(003):172-175.
[282]吴晓慧.丹皮酚的磺化产物鉴定及抑菌作用的比较南京师大学报:自然科学版,2003. 26(004): 99-102.
[283]林英光,姚煜东.超临界萃取丹皮酚在牙膏中的应用研究牙膏工业,2002,(002): 27-29.
[284] Verberne M. Overproduction of salicylic acid in plants by bacterial transgenes enhances pathogen resistance. Nature biotechnology, 2000,18(7):779-783.
[285] Delaney T. A central role of salicylic acid in plant disease resistance. Science, 1994,266(5188): 1247-1250.
[286] Wildermuth M..Isochorismate synthase is required to synthesize salicylic acid for plant defence. Nature,2001,414(6863):562-565.
[287] Farber B.,A. Wolff. Salicylic acid prevents the adherence of bacteria and yeast to silastic catheters. Journal of biomedical materials research, 1993. 27(5)599-602.
[288] Li F., X. Zhou, H. Mao. A study of paeonol injection on immune functions in rats.中国中西医结合杂志.1994,14(1): 37-42.
[2]陆志科,谢碧霞.竹叶化学成分的分析与资源的开发利用林业科技开发, 2003. 17(1):6-9.
[3]郭雪峰,孟志芬,熊彩云.竹子天然产物种类及其加工利用的研究世界竹藤通讯, 2006,4(002):1-4.
[4]杜孝元.酪氨酸酶活性抑制实验及其在祛斑美白化妆品功效评价中的应用中国美容医学,2005(6):740-742.
[5]李洪武,朱文元.白癜风丸及其组方中药对酪氨酸酶活性的影响中国麻风皮肤病杂志,2007(1):39-40.
[6]欧志敏.酪氨酸酶的应用研究进展中国生物工程杂志,2005(B04): 163-169.
[7]李洪武,朱文元.白术及茯苓提取物对豚鼠皮肤酪氨酸酶mRNA基因表达水平的影响.中华皮肤科杂志,2001(2):134-135.
[8] Kittlesen, D. Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development 1. The Journal of Immunology,1998,160(5): 2099-2106.
[9]李韶勇,孙命.黑色素的合成及其常见抑制剂的作用机理天津师范大学学报:自然科学版,2002(1):17-21.
[10]龚静.红景天水提液对酪氨酸酶抑制效果的初步研究四川大学学报:自然科学版, 2006(2): 468-471.
[11]韩强,林惠芬.几种中药提取物对酪氨酸酶活性的抑制香料香精化妆品,1998(4):22-24.
[12]弓晓杰.桔梗中抑制酪氨酸酶活性成分的研究中药材,2004(4): 257-259.
[13]吴皓.橘皮中的酪氨酸酶抑制剂蜜橘黄素国外医学:中医中药分册,2004(1): 51-51.
[14]王福兴,陈前进.具抑制酪氨酸酶活性祛斑增白药物中国医院药学杂志,1999(8): 479-480.
[15]陈清西,宋康康.酪氨酸酶的研究进展厦门大学学报:自然科学版,2006(5):731-737.
[16]陈清西,林建峰,宋康康.酪氨酸酶抑制剂的研究进展厦门大学学报:自然科学版,2007(2): 274-282.
[17]王寒清,王昌涛,董银卯.美白化妆品的功能评价方法日用化学品科学,2007(2):32-34.
[18]唐海谊,何冠邦,周喜林.美白中药之水及乙醇提取物对酪氨酸酶抑制功效之比较中国药学杂志,2005(5):342-343.
[19] Pomerantz, S. L-tyrosine-3, 5-3H assay for tyrosinase development in skin of newborn hamsters. 1969,10(6)838-839.
[20] Chen, Y. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proceedings of the National Academy of Sciences, 1995. 92(18): 8125-8129.
[21] Svitel. J.,S. Miertus. Development of tyrosinase-based biosensor and its application for monitoring ofbioremediation of phenol and phenolic compounds. Environ. Sci. Technol, 1998,32(6):828-832.
[22] Anh.T. Development of tyrosinase biosensor based on pH-sensitive field-effect transistors for phenols determination in water solutions. Talanta, 2002,56(4):627-634.
[23] Carralero Sanz. Development of a tyrosinase biosensor based on gold nanoparticles-modified glassy carbon electrodes Application to the measurement of a bioelectrochemical polyphenols index in wines. Analytica Chimica Acta, 2005,528(1):1-8.
[24] Dempsey E., D. Diamond, A. Collier. Development of a biosensor for endocrine disrupting compounds based on tyrosinase entrapped within a poly (thionine) film. Biosensors and Bioelectronics, 2004,20(2):367-377.
[25]徐幸莲,陈伯祥.黑色素的研究进展中国畜产与食品, 1997,4(3):135-137.
[26]肖燕,李青峰.色素研究进展中华临床医药杂志(北京),2003,4(12):45-46.
[27]赵肃清,蔡燕飞.天然黑色素的研究进展广州食品工业科技,2001,17(3): 54-55.
[28]兰风华,高磊.白癜风自身免疫机理的研究进展上海免疫学杂志,1998,18(4): 250-252.
[29]高天文,刘荣卿.恶性黑素瘤病因及病理机制研究进展实用肿瘤杂志,1998, 13(6): 323-325.
[30]杨翠红.人类黑色素瘤抗原的研究进展国外医学:免疫学分册,1998,21(2):68-71.
[31]吴品茹,刘健航.角质形成细胞在色素增加性疾病中的作用研究进展中国美容医学,2007,16(5):703-705.
[32]程东庆,尉晓冬.复方中药对小鼠b-16黑素瘤细胞株黑素合成和酪氨酸酶的激活作用中华皮肤科杂志,2000(3):173-174.
[33]邹先伟,蒋志胜.植物源酪氨酸酶抑制剂研究进展中草药,2004(6):702-705.
[34]李飞跃.竹叶主要化学成分分析及其生物活性研究现状江西林业科技,2006,4:34-36.
[35]李洪玉,孙静芸,戴诗文.竹叶化学成分研究中药材,2003,26(8):562-563.
[36]李少鹏.竹叶提取物的抗血栓作用研究中国热带医学, 2005,5(6):1202-1204.
[37]林凯.淡竹竹叶挥发油成分分析.江西农业学报,2009,21(2):92-93.
[38]陆志科,谢碧霞.竹叶活性成分分析及其提取物抗菌效果中南林学院学报, 2004, 24(4): 70-73.
[39]陆志科,谢碧霞.不同种竹叶的化学成分及其提取物抗菌活性的研究西北林学院学报, 2005,20(1):49-52.
[40]马世玉.竹叶水溶性提取液抗氧化作用的实验研究时珍国医国药,2005,16(6):472-473.
[41]马世玉.竹叶提取液抗氧化作用的实验研究.中国老年学杂志,2005,25(1):93-94.
[42]马世玉.竹叶提取液对小鼠的抗氧化作用中国临床药理学与治疗学,2004,9(5):585-587.
[43]许宝泉,吴水英,宋秋华.竹叶黄酮的生理功能研究进展江西林业科技,2006,1:37-39.
[44]周琦.竹叶提取物的抗血栓作用沈阳药科大学学报,2006,23(7):459-462.
[45]郭雪峰.用清除有机自由基DPPH法评价竹叶提取物抗氧化能力光谱学与光谱分析, 2008,28(007): 1578-1582.
[46]蒋企洲.箬竹叶黄酮对油脂的抗氧化性研究实用临床医药杂志,2008,12(4): 50-51.
[47]宋仲容.竹叶提取物的抗氧化活性研究化学研究与应用,2006,18(1):67-69.
[48]张英,丁霄霖.竹叶有效成分和抗活性氧自由基效能的研究竹子研究汇刊,1996,15(003): 17-24.
[49] Kweon. M., H. Hwang, H. Sung. Identification and antioxidant activity of novel chlorogenic acid derivatives from bamboo (Phyllostachys edulis). J. Agric. Food Chem,2001,49(10):4646-4655.
[50] Park H. Antioxidant flavone glycosides from the leaves of Sasa borealis. Archives of pharmacal research,2007,30(2):161-166.
[51]张英.竹叶黄酮的生理与药理活性世界竹藤通讯,2004,2(2):1-11.
[52] Mu J. Identification and evaluation of antioxidant activities of bamboo extracts. Forestry Studies in China, 2004, 6(2):1-5.
[53] Xue-feng GUO. Detection of Antioxidative Capacity of Bamboo Leaf Extract by Scavenging Organic Free Radical DPPH. Spectroscopy and Spectral Analysis, 2008,28 (07): 1578-1582
[54] Zhang Y.,X. Ding. The bio-antioxidative activity of functional factors in bamboo leaves, Wiley,2005[J]
[55] Zhang Y. Isolation and purification of four flavone C-glycosides from antioxidant of bamboo leaves by macroporous resin column chromatography and preparative high-performance liquid chromatography. Food Chemistry, 2008. 107(3): 1326-1336.
[56] Zhang Y., X.Q. Wu. Comparison study on total flavonoid content and anti-free redical activity of the leaves of bamboo, phyllostachys nigra, and Ginkgo bilabo. Zhongguo Zhong Yao Za Zhi, 2002. 27(4): 254-7.
[57]孙长花,张素华,张凌云.竹叶黄酮的生理活性与应用研究四川食品与发酵,2006,42(1): 13-16.
[58]吴三林,李书华,弓加文.竹叶活性成分的研究进展乐山师范学院学报, 2005. 20(5): 53-54.
[59]高志强,江相兰,宋仲容.竹叶中黄酮类化合物的研究进展评述西南民族大学学报:自然科学版,2005. 31(1):38-43.
[60]支崇远.玉米花粉黄酮类物质对SD大鼠降血脂作用的研究放射免疫学杂志,2002. 6.
[61]张洪坤.竹叶的保健功能及应用山东商业职业技术学院学报, 2005. 5(002):91-94.
[62]张英,陆柏益,吴晓琴.竹叶黄酮的心脑血管药理活性研究中国食品添加剂,2005,C00:59-66.
[63]王谦.竹文化与竹康宁世界竹藤通讯,2004,2(002):26-30.
[64]袁秀英,心脑血管病的预防与竹康宁世界竹藤通讯,2004,2(002):12-16.
[65]陆柏益,张英,吴晓琴.竹叶黄酮的抗氧化性及其心脑血管药理活性研究进展林产化学与工业, 2005. 25(3):120-124.
[66]杨抚林.竹叶提取物中功能性成分及效用中国食物与营养,2004,(005):53-55.
[67]张佐玉,张喜.竹子在中医药和保健品开发中的潜力世界科学技术:中药现代化,2000,2(003):54-56.
[68]黄占旺,邹双双,熊水波.毛竹叶提取物抑菌作用的初步研究江西农业大学学报, 2005, 27(006):960-963.
[69]岳永德,操海群,汤锋.竹提取物的化学成分及其利用研究进展安徽农业大学学报,2007,34(003):328-333.
[70]谢碧霞,陆志科.麻竹叶抑菌活性成分的分离鉴定中南林学院学报,2005,25(005):10-14.
[71]许丽旋,蔡建秀.竹笋壳黄酮提取液抑菌效应初步研究世界竹藤通讯,2006,4(004):29-31.
[72]蔡建秀.竹笋壳黄酮提取液抑菌效应初步研究世界竹藤通讯,2006(04).
[73]黄亚利,操海群.毛竹叶提取物不同流份抑菌活性评价安徽农学通报, 2008,14(14): 108-109.
[74]黄文,王益.竹叶的化学成份及应用进展中国林副特产,2002,(003):65-66.
[75]丁玉强,陈春英.箬叶水溶性多糖的色谱研究色谱, 1996,14(006):470-472.
[76]姚旌旗,李映红.竹叶提取液对ASP-Ⅰ肺癌细胞生长的影响咸宁医学院学报, 2002,16(001): 21-22.
[77]江庆中,刘景致.箬竹酒研究江西林业科技,1999(002):14-15.
[78]刘翠,王文久.竹叶资源研究进展及开发利用:兼谈云南丛生竹竹叶资源开发对策林业建设,1999(006):10-14.
[79]吕兆林.毛竹叶挥发油的提取方法北京林业大学学报, 2008. 30(4): 135-140.
[80]毛燕,刘志坤.毛竹叶挥发性成分的提取与GC-MS分析福建林学院学报,2001,21(003): 265-267.
[81]王学利,毛燕.箬竹叶挥发性成分GC-MS分析竹子研究汇刊,2001,20(002): 36-38.
[82]张英,汤坚.竹叶精油和头香的OGC-MS-DS研究天然产物研究与开发, 1998,10(004): 38-44.
[83]高丽欣.慈竹叶精油化学成分研究天然产物研究与开发,2002,14:(06)35-40.
[84]廖威.毛竹叶化学成分的初步测定山西大学学报(自然科学版), 2003,26:(01)46-48.
[85]张英,唐莉莉.竹叶功能因子生物抗氧化性质的研究营养学报,1998,20(003):367-371.
[86]郝培应,徐有明,皮忠来.竹类植物衍生物的生理活性及其疗效的研究进展世界林业研究, 2004,17(003): 21-24.
[87]莫开菊,张中利.竹叶提取物对微生物抑制作用研究湖北民族学院学报:自然科学版, 2000,18(004): 16-18.
[88]郝培应,肖家军,齐笑笑.紫竹叶提取物的抑菌效果研究安徽农业科学, 2008,36(7): 2810-2812.
[89]操海群,岳永德.竹提取物对玉米蟓Sitophilus zeamais Motsch生物活性的初步研究.农药学学报,2002,4(001):80-84.
[90]操海群.竹提取物对蚜虫生物活性的研究植物保护,2003,29(002):33-36.
[91]张英.天然功能性竹叶提取物-竹叶黄酮中国食品添加剂,2002,(003):54-58.
[92] Lu B. Toxicology and safety of anti-oxidant of bamboo leaves. Part 1: Acute and subchronic toxicitystudies on anti-oxidant of bamboo leaves. Food and chemical toxicology, 2005,43(5): 783-792.
[93]王腾凤.竹叶提取物及其在口腔护理中的应用.牙膏工业,2005,(003):15-17.
[94] Chikako Masuoka, M.O., Yasuyuki ITO,Toshihiro Nohara. Antioxidative, Antihyaluronidase and Antityrosinase Activities of Some Constituents from the Aerial Part of Piper elongatum VAHL. Food Sci. Technol. Res.,2003. 9(2):197–201.
[95] Lerner, A. Mammalian tyrosinase: the relationship of copper to enzymatic activity. Journal of Biological Chemistry,1950. 187(2):793-802.
[96]曲娜,郁铭.酪氨酸酶活性中心模型化合物的合成与表征天津师范大学学报:自然科学版, 2003(1):17-19.
[97] Masamoto, Y. Mushroom Tyrosinase Inhibitory Activity of Esculetin Isolated from Seeds of Euphorbia lathyris L. Bioscience, Biotechnology, and Biochemistry, 2003, 67(3):631-634.
[98] Te-Sheng Chang, H.-Y.D., Hang-ching Lin, Identifying 6,7,4'-Trihydroxyisoflavone as a potent tyrosinase inhibitor. Biosci. Biotechnol. Biochem., 2005,69(10):1999-2001.
[99]雷铁池.酪氨酸酶基因家族与皮肤黑素生成.国外医学:皮肤性病学分册,1998(2):81-85.
[100]杨舒黎,毛华明.酪氨酸酶基因研究进展动物科学与动物医学,2003,(9):22-23.
[101]元建鹏.酪氨酸酶基因在hek293细胞表达的mri评价中国病理生理杂志,2003,(9): 1210-1213.
[102]元建鹏,梁碧玲.酪氨酸酶基因在HepG2细胞中表达的MR评价及其方法.癌症,2003,22(2):156-159.
[103]李春英,高天文.酪氨酸酶相关蛋白-1的基因克隆表达及纯化中国皮肤性病学杂志,2001,15(6):368-370.
[104]赵会全,刘望夷.酷氨酸酶的分子生物学研究进展国外医学:分子生物学分册,1991,13(006):273-275.
[105] Kawabata T. Molecular cloning of insect pro-phenol oxidase:a copper-containing protein homologous to arthropod hemocyanin. Proceedings of the National Academy of Sciences, 1995,92(17): 7774-7778.
[106] Orlow S. High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: Evidence for a melanogenic complex. Journal of Investigative Dermatology,1994,103(2):196-201.
[107] Jackson. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. The EMBO Journal,1992,11(2):527.
[108] Vijayasaradhi S. Melanocyte differentiation marker gp75, the brown locus protein, can be regulated independently of tyrosinase and pigmentation. Journal of Investigative Dermatology,1995,105(1): 113-119.
[109] Hume A. Rab27a regulates the peripheral distribution of melanosomes in melanocytes. Journal of Cell Biology,2001,152(4):795-808.
[110] Jimbow K. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins inthe initial stage of melanosome biogenesis.Pigment Cell Res,2000,13(4):222-229.
[111] Casella L. Hemocyanin and tyrosinase models. Synthesis, azide binding, and electrochemistry of dinuclear copper (II) complexes with poly (benzimidazole) ligands modeling the met forms of the proteins. Inorganic Chemistry, 1993, 32(10):2056-2067.
[112] Ross,E. Solomon.An electronic structural comparison of copper-peroxide complexes of relevance to hemocyanin and tyrosinase active sites. Journal of the American Chemical Society, 1991,113(9): 3246-3259.
[113] Rompel A. Purification and spectroscopic studies on catechol oxidases from Lycopus europaeus and Populus nigra: evidence for a dinuclear copper center of type 3 and spectroscopic similarities to tyrosinase and hemocyanin. Journal of Biological Inorganic Chemistry, 1999,4(1):56-63.
[114] Baldwin M. Spectroscopic and theoretical studies of an end-on peroxide-bridged coupled binuclear copper (II) model complex of relevance to the active sites in hemocyanin and tyrosinase. Journal of the American Chemical Society, 1991,113(23):8671-8679.
[115] Pate J. Spectroscopic studies of the charge transfer and vibrational features of binuclear copper (II) azide complexes: comparison to the coupled binuclear copper active site in met azide hemocyanin and tyrosinase. Journal of the American Chemical Society, 1989,111(14):5198-5209.
[116] Decker H. , F. Tuczek. Tyrosinase catecholoxidase activity of hemocyanins: structural basis and molecular mechanism. Trends in Biochemical Sciences, 2000,25(8):392-397.
[117] Spritz R. Mutational Analysis of Copper Binding by Human Tyrosinase. Journal of Investigative Dermatology, 1997,109(2):207-212.
[118]王戈林,宁华.酪氨酸酶基因工程菌产黑色素的发酵条件研究中国医药工业杂志, 1999,(4): 150-154.
[119]曹广文,崔龙.酪氨酸酶启动子调控的cd基因治疗恶性黑色素瘤第二军医大学学报, 1998(3): 205-208.
[120]杨如义,郑能武.酪氨酸酶同功酶的抑制作用研究中国科学技术大学学报, 2000(4): 492-499.
[121]王秋枫.酪氨酸酶相关蛋白家族中国美容医学,2003(1):100-103.
[122] Lerro K.,G. Prestwich. Cloning and sequencing of a cDNA for the hemolymph juvenile hormone binding protein of larval Manduca sexta. Journal of Biological Chemistry,1990,265(32):19800-19806.
[123] Hall M. Proenzyme of Manduca sexta phenol oxidase: purification, activation, substrate specificity of the active enzyme, and molecular cloning. Proceedings of the National Academy of Sciences, 1995,92(17): 7764-7768.
[124] Kramer K. Oxidative conjugation of catechols with proteins in insect skeletal systems. Tetrahedron, 2001,57(2): 385-392.
[125] Dittmer N. Characterization of cDNAs encoding putative laccase-like multicopper oxidases and developmental expression in the tobacco hornworm, Manduca sexta, and the malaria mosquito,Anopheles gambiae. Insect biochemistry and molecular biology,2004,34(1):29-41.
[126] Morris S.,W. Muir. Dinucleotide repeat polymorphism at the human tyrosinase gene. Nucleic acids research,1991,19(24):6968.
[127] Bouchard B.. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. Journal of Experimental Medicine,1989,169(6):2029-2042.
[128] Takase M.. Cloning and sequencing of the cDNA encoding tyrosinase of the Japanese pond frog, Rana nigromaculata. Gene, 1992,121(2):359.
[129] Kwon T.. Purification and characterization of prophenoloxidase from the hemolymph of coleopteran insect, Holotrichia diomphalia larvae. Molecules and Cells (Korea Republic),1997,7(1):90-97.
[130] Bernan V.. The nucleotide sequence of the tyrosinase gene from Streptomyces antibioticus and characterization of the gene product. Gene(Amsterdam), 1985, 37(1-3):101-110.
[131] Somkuti G.,D. Solaiman,D. Steinberg. Cloning of a tyrosinase gene in Streptococcus thermophilus. Biotechnology Letters, 1993,15(8):773-778.
[132] Lee, Y. A trans-acting gene is required for the phenotypic expression of a tyrosinase gene in Streptomyces. Gene, 1988,65(1):65-71.
[133] Lee M. ,J. Anstee. Phenoloxidase and Its Zymogen from the Haemolymph of Larvae of the Lepidopteran Spodoptera Littoralis (Lepidoptera: Noctuidae). Comparative biochemistry and physiology. Part B. Biochemistry & molecular biology,1995,110(2):379-384.
[134] Ikeda K. Cloning and sequence analysis of the highly expressed melanin-synthesizing gene operon from Streptomyces castaneoglobisporus. Applied microbiology and biotechnology,1996,45(1):80-85.
[135] Kawamoto S., M. Nakamura, S. Yashima. Cloning, Sequence and Expressin of the Tyrosinase Gene from Streptomyces lavendulae MA406 A-1. Journal of fermentation and bioengineering,1993,76(5):345-355.
[136] Zhao H.. Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a TRP-1-deficient melanoma cell line. Journal of Investigative Dermatology,1996,106(4):744-752.
[137] Hasselmann D. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Am Assoc Clin Chem,2001,47:1488-1489.
[138] Tan Cheng, Zhu Wenyuan, LU Yan. Aloin,cinnamic acid and sophorarpidine are potent inhibitiors of tyrosinase. Chinese Medical Jounal,2002,115(12):1859-1862.
[139] Bin Wu. Complex Sesquiterpenoids with Tyrosinase Inhibitory Activity from the Leaves of Chloranthus tianmushanensis. American Chemical Society and American Society of Pharmacognosy,2008,71(5):877-880
[140] Zhen Yang ,Ya-Jun Yue, Miao Xing. Tyrosinase activity in ionic liquids. Biotechnol Lett,2008,30:153-158.
[141] Zong-Ping Zheng. Tyrosinase inhibitors from paper mulberry. Food Chemistry. 2008,106:529-535.
[142]李玲,宋伟民,周华. 4种美白剂对b-16细胞内酪氨酸酶活性抑制的研究.宁夏医学院学报, 2006,(1): 10-12.
[143] Kejun C., C. Jing, L. Gao. Taxiphyllin:A Cyanogenic Glucoside with Tyrosinase Inhibitory Activity from the Shoots of Pleioblastus amarus. Natural Product and Development, 2005,17(6):733-742.
[144]涂彩霞. 6味中药乙醇提取物对B16黑素瘤细胞酪氨酸酶及其相关蛋白-1、-2 mRNA表达的影响.中华皮肤科杂志, 2007(2):104-106.
[145]任冰如,吴菊兰. 6种植物提取物对酪氨酸酶活性的影响植物资源与环境学报,2003(1):58-59.
[146]王建华,雷帆. 10种中药对酪氨酸酶激活作用的研究中国中医药信息杂志,2000,(4):40-40.
[147]闫军. 14味中药对酪氨酸酶抑制作用的探讨.中国药房,2003(7):442-443.
[148]杨柳依. 14种中药提取成分对酪氨酸酶活性的抑制作用中华皮肤科杂志,2003,(4):207-209.
[149]杨景冲,王晓岚,金坚.滨海白首乌提取物对酪氨酸酶活力的影响天然产物研究与开发,2007,(5): 753-756.
[150]邰晓曦,孙婧,邓湘庆.薄荷中乌发组分的初步探索广东化工,2007,(4):45-46,62.
[151]徐建国.尚靖.补骨脂对酪氨酸酶的激活作用中草药,1991(4):168-169.
[152]王锡元,王建新.补骨脂素复配物对酪氨酸酶协同激活性能研究天然产物研究与开发, 2007(1):77-80.
[153]戴新荣,董丽敏,张验军. 2,4,6,4'-四羟基脱氧安息香的合成及其抑制酪氨酸酶活性的研究香料香精化妆品,2007,(3):7-9.
[154]张丽娟. 3-羟基苯甲酸对酪氨酸酶的抑制作用和抑菌作用厦门大学学报:自然科学版,2006,(5):705-708.
[155] Sang Yoon CHOI, S. K. Hocheol KIM. (4-Methoxy-benzylidene) -(3-methoxy-phenyl)-amine, a Nitrogen Analog of Stilbene as a Potent Inhibitor of Melanin Production. Chem. Pharm. Bull., 2002,50(4):450-452.
[156] Pierre C. Antimelanogenic Activity of 3,4-Dihydroxyacetophenone Inhibition of Tyrosinase and MITF. biosci. Biotechnol. Biochem., 2006,70(2):532-534.
[157] Derivatives K.,Keloa T. Antimicrobial and Tyrosinase Inhibitory Activities of 6-[ ( 8Z )-8-Pentadecenyl]salicylic Acid Derivatives. Journal of OLEO Science,2002,51(10):637-642.
[158] Duck Hee KIM, J.-S.H., Heung Soo BAEK. Development of 5-[(3-Aminopropyl) phosphinooxy]-2-(hydroxymethyl)-4Hpyran-4-one as a Novel Whitening Agent. Chem. Pharm. Bull., 2003,51(2):113-116.
[159] Chien, C. C. Effects on Tyrosinase Activity by the Extracts of Ganoderma lucidum and Related Mushrooms. Mycopathologia, 2008. 166(2):117-120.
[160] Yun-Hee CHANG. a Minhwan JUNG, Inhibition of Melanogenesis by Selina-4(14),7(11)-dien-8-one Isolated from Atractylodis Rhizoma Alba. Biol. Pharm. Bull,2007,30(4):719-723.
[161] Sang Keun HA, Kunho LEE. Inhibition of Tyrosinase Activity by N,N-Unsubstituted SelenoureaDerivatives. Biol. Pharm. Bull, 2005,28(5):838-840.
[162] Kyung-Hee PARK, Hwa-Sun HAHN. Inhibitory Effect of Ammonium tetrathiotungstate on Tyrosinase and Its Kinetic Mechanism. Chem. Pharm. Bull.,2006,54(9):1266-1270.
[163]龚盛昭,程江,杨卓如. Inhibitory Effect of Ferulic Acid on Oxidation of L-DOPA Catalyzed by Mushroom Tyrosinase.中国化学工程学报:英文版,2005(6):771-775.
[164] Szu-Hsiu LIU, I-Ming CHU. Inhibitory Effect of p-Hydroxybenzyl Alcohol on Tyrosinase Activity and Melanogenesis. Biol. Pharm. Bull,2007,30(6):1135-1139.
[165] Likhitwitayawuid K. , B. Sritularak. A new dimeric stilbene with tyrosinase inhibitory activity from Artocarpus gomezianus. J. Nat. Prod., 2001,64 (11), 1457–1459
[166] DaiRongYuan. Ortho-Hydroxylation of Phenol by Tyrosinase Model Compounds.中国化学快报:英文版, 2005,(2):147-150.
[167]程科军. Taxiphyllin:苦竹笋中具有酪氨酸酶抑制活性的氰苷天然产物研究与开发,2005(6):733-735,772.
[168] Kubo I., I. Kinst-Hori, Y. Yokokawa. Tyrosinase Inhibitors from Anacardium occidentale Fruits. Journal of Natural Products, 1994,57(4):545-551.
[169] Kubo I., Y. Yokokawa, I. Kinst-Hori. Tyrosinase Inhibitors from Bolivian Medicinal Plants. Journal of Natural Products, 1995,58(5):739-743.
[170] Firoza Khanom H.K.,K.T. Tyrosinase Inhibitory Activity of Bangladeshi Indigenous Mediacal Plants. Biosci. Biotechnol. Biochem.,2000,64(9):1967-1969. 171 Gandia-Herrero. Tyrosinase Inhibitory Activity of Cucumber Compounds: Enzymes Responsible for Browning in Cucumber. Journal of Agricultural and Food Chemistry, 2003,51(26):7764-7769.
[172] Soo Jin KIM, K.H.S., Hyun Wook Chang. Tyrosinase Inhibitory Prenylated Flavonoids from Sophora flavescens. Biol. Pharm. Bull.,2003,26(9):1348-1350.
[173] Xiang Lan PIAO, Man Ki PARK. Tyrosinase-Inhibitory Furanocoumarin from Angelica dahurica. Biol. Pharm. Bull.,2004,27(7):1144-1146.
[174] Sher Bahadar KHAN A., Nighat AFZA. Tyrosinase-Inhibitory Long-Chain Esters from Amberboa ramosa. Chem. Pharm. Bull.,2005,53(1):86-89.
[175]乔薇.苯甲醛及其类似物对酪氨酸酶抑制作用的研究中山大学学报:自然科学版, 2007,(5):41-44.
[176]黄璜,刘晓丹.苯甲醛族化合物抑制蘑菇酪氨酸酶活力的研究厦门大学学报:自然科学版, 2003,(1):97-101.
[177]刘晓丹,黄璜.苯甲酸对蘑菇酪氨酸酶抑制作用机理的研究厦门大学学报:自然科学版, 2003,(1):102-106.
[178]曾伟成and郑能武,苯甲酸钠对酪氨酸酶的抑制作用数理医药学杂志,2000,(2):161-161.
[179]赵荧,郑玉娟.对羟基苯甲酸对酪氨酸酶的抑制作用吉林大学自然科学学报,1998,(4): 89-90.
[180]龚盛昭,邓相庆,李仕梅.对羟基肉桂酸抑制酪氨酸酶活性的动力学研究日用化学工业, 2006(3):159-162.
[181]王勤.对氰基苯酚对蘑菇酪氨酸酶的抑制作用厦门大学学报:自然科学版, 2004,(4):568-571.
[182]黄浩.对醛基苯甲酸对蘑菇酪氨酸酶的抑制作用厦门大学学报:自然科学版,2005(4): 566-568.
[183]徐亮.酪氨酸酶催化的3,4二羟基苯基丙氨酸氧化反应的动力学分析四川大学学报:自然科学版,2005,(6):1271-1273.
[184]徐迪.酪氨酸酶催化对位取代苯酚和芳香胺的反应及其意义有机化学,2003(7):724-727.
[185]曾伟成,朱道清.酪氨酸酶催化反应机理的动力学分析数理医药学杂志,1999(2):158-158.
[186]徐迪,马林.酪氨酸酶催化氧化羟基吡啶类化合物的反应研究中山大学学报:自然科学版, 2002(6):33-35.
[187]李新荣,韩红.酪氨酸酶的酶学动力学研究南京铁道医学院学报,1992,11(1):33-36.
[188] Xue C.B. 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors. Bioorganic & Medicinal Chemistry, 2007,15(5):2006-2015.
[189] Xue C.B. Quantitative structure–activity relationship studies of mushroom tyrosinase inhibitors. Journal of Computer-Aided Molecular Design, 2008,22(5):299-309.
[190]路红星.发酵法制曲酸的研究应用四川食品与发酵,2001,(3):17-22.
[191]张廷红,葛长海,万海清.酪氮酸酶的应用研究进展沿海企业与科技,2005,(2):161-163.
[192]段玉清,刘睿,谢笔钧.莲房原花青素对酪氨酸酶活力和黑色素生物合成影响的初步研究食品科学, 2004,25(3): 169-174.
[193]操海群.竹提取物对棉铃虫幼虫及菜青虫的拒食活性昆虫知识,2005,42(2):171-174.
[194]操海群.竹提取物对棉铃虫幼虫体内几种酶系活性的影响林业科学,2006,42(7): 145-148.
[195]谢桂英,罗万春.天然源化合物曲酸对小菜蛾酚氧化酶抑制作用研究初报农药学学报,2003(001):68-72.
[196] Reinhold U. The Analysis of Tyrosinase-Specific mRNA in Blood Samples of Melanoma Patients by RT-PCR Is Not a Useful Test for Metastic Tumor Progression. Journal of Investigative Dermatology,1997,108(2):166-169.
[197] Lewis J. Evaluation of CD8+ T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. International Journal of Cancer, 2000,87:(3)114-119.
[198] Korner A. ,J. Pawelek. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science, 1982,217(4565):1163-1165.
[199] Spagnoli G. Peptide-specific CTL in tumor-infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes:a study in an unselected group of HLA-A2. 1-positive patients. International Journal of Cancer, 1995. 64(5).
[200]伍革民,彭光旭.动物黑色素研究进展甘肃畜牧兽医,2005,35(1):39-41.
[201]乌新春,段晰所.恶性黑色素瘤的研究进展承德医学院学报, 2008, 25(3): 309-312.
[202]廖贵清.恶性黑色素瘤治疗的研究进展国外医学:口腔医学分册, 1994,21(2): 83-85.
[203]刘亚玲.恶性黑素瘤治疗进展河北医科大学学报,2006,27(5):506-509.
[204]舒文,毛华明.黑色素的研究进展国外畜牧学:猪与禽,2003,2:31-34.
[205]谭玉文.神经黑色素的研究进展中国畜牧兽医,2008. 35(7):52-55.
[206]李文,邓卫东,毛华明.乌骨绵羊和黑色素的研究进展家畜生态学报,2007,28(3):1-5.
[207] Kameyama K. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. Journal of Investigative Dermatology, 1993,100(2):126-131.
[208]刘甲斐,仇雪梅.黑色素及其相关基因的研究进展生物技术通报,2007,4:55-58.
[209]钱海利,林晨.黑色素瘤分化相关基因-7研究进展国外医学:肿瘤学分册,2004. 31(2): 87-89.
[210]李春英,高天文.恶性黑色素瘤基因研究新进展实用肿瘤杂志,1998,13(6):321-322.
[211] Hussussian C. Germline p16 mutations in familial melanoma. Nature genetics, 1994, 8(1): 15-21.
[212] Metharom K. Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma. Human gene therapy, 2001,12(18):2203-2213.
[213] Spencer J. The Ca2+ Binding Capacity of Epidermal Furin Is Disrupted by H2O2-Mediated Oxidation in Vitiligo. Endocrinology, 2008, 149(4):1638.
[214] Shaker O.,S. El-Tahlawi. Is there a relationship between homocysteine and vitiligo? A pilot study. British Journal of Dermatology, 2008,159(3):720.
[215] Gavalas N. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Experimental Dermatology, 2009. 4:(5)119-124
[216] SMITH S.,B. Zhou,S. ORLOW. Expression of Tyrosinase and the Tyrosinase Related Proteins in theMitfvit (Vitiligo) Mouse Eye: Implications for the Function of the Microphthalmia Transcription Factor (Mitf). Experimental eye research,1998,66(4):403-410.
[217] Okamoto T. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. Journal of Investigative Dermatology, 1998,111(6): 1034-1039.
[218] Jimbow K. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. British Journal of Dermatology, 2001. 144(1): 55.
[219]张琳西,王臻.中波紫外线对体外培养的人黑色素细胞的影响中国美容医学, 2001,10(003):180-182.
[220]SONG Y.The role of tyrosinase in autoimmune vitiligo. Lancet(British edition),1994,344 (8929):1049-1052.
[221] Kemp E. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. Journal of Investigative Dermatology, 1997. 109(1):69-73.
[222] Kemp, E., et al., Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. British Journal of Dermatology, 1998,139(5):798.
[223] Gottumukkala R. Function-blocking autoantibodies to the melanin concentrating hormone receptor in vitiligo patients. Laboratory Investigation,2006,86(8):781-789.
[224] Stierner U. UVB irradiation induces melanocyte increase in both exposed and shielded human skin. Journal of Investigative Dermatology, 1989,92(4):561-564.
[225] Ramirez-Bosca, A., et al., Effect of the dose of ultraviolet radiation on the pigment formation by human melanocytes in vitro. Archives of Dermatological Research, 1992, 284(6):358-362.
[226] LIBOW, L., S. SCHEIDE, and V. DeLeo, Ultraviolet radiation acts as an independent mitogen for normal human melanocytes in culture. Pigment Cell Research, 1988,1(6):397-401.
[227] DUVAL C., M. REGNIER, R. SCHMIDT. Distinct Melanogenic Response of Human Melanocytes in Mono-culture, in Co-Culture with Keratinocytes and in Reconstructed Epidermis, to UV Exposure. Pigment Cell Research, 2001,14(5):348.
[228] Gilchrest B. Mechanisms of ultraviolet light-induced pigmentation. Photochemistry and photobiology,1996,63(1):1-10.
[229] Neil S. Stimulation of the adenylate cyclase of a B16 melanoma cell line by pro-opiocortin-related peptides-A structure-activity study. Regulatory Peptides, 1981,2(3):193-200.
[230] Sato H. The Expression of Corticotropin-Releasing Hormone in Melanoma. Pigment Cell Research, 2002,15(2):98.
[231] Hunt G. Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. 1994,107(1):205-211.
[232] Schith H. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. European journal of pharmacology, 1997,319(2-3):369-373.
[233] Schioth, H., R. Muceniece, and J. Wikberg, Characterisation of the melanocortin 4 receptor by radioligand binding. Pharmacology & toxicology, 1996,79(3):161.
[234]杨柳,吕荣锋.黑素细胞刺激素在不同实验动物表皮中的表达及意义浙江中医药大学学报,2008,32(1):27-29.
[235] SCHALLREUTER K -MSH can control the essential cofactor 6-tetrahydrobiopterin in melanogenesis. Annals of the New York Academy of Sciences,1999,885(1):329-341.
[236] Hunt G. Nle4DPhe7&agr ; -Melanocyte-Stimulating Hormone Increases the Eumelanin :Phaeomelanin Ratio in Cultured Human Melanocytes. Journal of Investigative Dermatology, 1995,104(1): 83-85.
[237] Wakamatsu K. Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Research, 1997,10(5):288-297.
[238]薛春雨. -MSH和MC-1R对表皮黑素细胞的调控作用实用美容整形外科杂志, 2003, 14(005):263-265.
[239]饶燕,刁庆春,王祝君.白癜风综合治疗疗效观察中华实用医药杂志, 2006. 6(23).
[240] Loir, B., et al., -Melanotropin immunoreactivity in human melanoma exudate is related to necrosis. European Journal of Cancer,1998,34(3):424-426.
[241] Wong W.,R. Minchin. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, d-Phe7] -MSH in B16 melanoma cells. International Journal of Biochemistry and Cell Biology, 1996, 28(11):1223-1232.
[242] Slominski A. Identification ofβ-endorphin, -MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Experimental Dermatology.1998,7(4):213-216.
[243] Smalley K.,T. Eisen. The involvement of p38 mitogen-activated protein kinase in the -melanocyte stimulating hormone ( -MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS letters.2000,476(3):198-202.
[244] Ghanem G . Evidence for alpha-melanocyte-stimulating hormone ( -MSH) receptors on human malignant melanoma cells. International Journal of Cancer, 1988. 41(2):248-255.
[245] Scott G.,L. Cassidy. Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model. Journal of Investigative Dermatology, 1998,111(2): 243-250.
[246] Siegrist W. Radioreceptor Assay for ;-Msh Using Mouse B16 Melanoma Cells. Journal of Receptors and Signal Transduction, 1988, 8(1-4):323-343.
[247] Abdel-Malek Z. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.2001,114(5):1019-1024.
[248] Siegrist W. Interactions of -melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. Journal of Receptors and Signal Transduction,1997,17(1):75-98.
[249] Siegrist, W., et al., Agouti Protein Inhibits Growth of B16 Melanoma Cellsin Vitroby Acting through Melanocortin Receptors. Biochemical and Biophysical Research Communications, 1996,218(1): 171-175.
[250] Blanchard, S., et al., Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line. Biochemistry, 1995,34(33):10406-10411.
[251] Voisey J.,G. Kelly,D. VAN. Agouti Signal Protein Regulation in Human Melanoma Cells. Pigment Cell Research,2003,16(1):65-71.
[252] Kanetsky K. A polymorphism in the agouti signaling protein gene is associated with human pigmentation. The American Journal of Human Genetics, 2002,70(3):770-775.
[253] Valverde C. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Human molecular genetics,1996,5(10):1663-1666.
[254] Lázár-Molnár E. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine,2000,12(6):547-554.
[255] Das K., A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends in immunology,2001,22(3):130-136.
[256] Seiberg M. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Experimental Cell Research, 2000,254(1):25-32.
[257] Buchdunger E. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. Journal of Pharmacology and Experimental Therapeutics, 2000,295(1):139-145.
[258] Berking C. Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. 2004,14:(6)807-811.
[259] Mattei S. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. International Journal of Cancer, 1994,56(6)853-857.
[260] Grabbe, J., et al., Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Archives of Dermatological Research, 1994,287(1):78-84.
[261] McGill, G. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell, 2002,109(6):707-718.
[262] Mackensen A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. International Journal of Cancer, 2000,86(3):64-72
[263] Huang, S. Enforced C-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene,1996,13(11): 2339-2347.
[264] Hopkins S., N. Rothwell. Cytokines and the nervous system I: expression and recognition. Trends in Neurosciences,1995,18(2):83-88.
[265] Kanik A., M. Yaar, J. Bhawan. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. Journal of cutaneous pathology,1996,23(3):205-210.
[266] Satyamoorthy K. Constitutive Mitogen-activated Protein Kinase Activation in Melanoma Is Mediated by Both BRAF Mutations and Autocrine Growth Factor Stimulation 2003,(9)756-759.
[267]陈永红.曲酸对动物的毒性研究及安全性评价食品科学,2007:09.
[268]赖椿根,马聿桓.箬竹叶水提取物化学成分研究浙江林学院学报,1995.12(002): 161-165.
[269] PatraA G., Sengupta P. K. Carbon 213 NMR spectral studies on chalcones and acetophenone. MagnReson Chem.,1987(25):734-742.
[270]于德泉,杨俊山.《分析化学手册(第七分册)-核磁共振波谱分析第一版》,化学工业出版社,1999
[271]章晓宁.无锡市市售酱腌菜、蜜饯中苯甲酸、山梨酸、糖精钠监测结果.职业与健康, 2007,23(15):1316-1317.
[272]依凡林.皮肤美白剂的比较日用化学品科学,1999,(006):13-14.
[273]宦萍.美白祛斑与安全中国检验检疫,2003,(007):56-57.
[274]邓瑞春,章金刚.驱虫斑鸠菊对B-16黑素瘤细胞酪氨酸酶活性及黑素生成影响氨基酸和生物资源,2002,24(001):31-34.
[275]艾文胜.箬竹丰产栽培及高效利用湖南林业科技,2004,31(004):15-17.
[276]陆志科,谢碧霞.竹叶化学成分的分析与资源的开发利用林业科技开发,2003,17(001): 6-9.
[277] Pieterse C. Systemic resistance in Arabidopsis induced by biocontrol bacteria is independent of salicylic acid accumulation and pathogenesis-related gene expression. The Plant Cell Online, 1996, 8(8):1225-1237.
[278]仲岳桐.高油脂食品中苯甲酸,山梨酸,糖精钠样品前处理的方法改进中国卫生检验杂志, 2001,11(004):471-471.
[279]郑国兴,张春乐,黄浩.水杨酸的抑酶与抑菌作用厦门大学学报自然科学版,2006,45(B05):19-22.
[280]朱恒英,陈永培.油茶饼中油茶皂甙体外抑菌试验福建中医药,1989,20(002):44-45.
[281]陈小红.水杨酸在银屑病治疗中的作用国外医学:皮肤性病学分册,2000,26(003):172-175.
[282]吴晓慧.丹皮酚的磺化产物鉴定及抑菌作用的比较南京师大学报:自然科学版,2003. 26(004): 99-102.
[283]林英光,姚煜东.超临界萃取丹皮酚在牙膏中的应用研究牙膏工业,2002,(002): 27-29.
[284] Verberne M. Overproduction of salicylic acid in plants by bacterial transgenes enhances pathogen resistance. Nature biotechnology, 2000,18(7):779-783.
[285] Delaney T. A central role of salicylic acid in plant disease resistance. Science, 1994,266(5188): 1247-1250.
[286] Wildermuth M..Isochorismate synthase is required to synthesize salicylic acid for plant defence. Nature,2001,414(6863):562-565.
[287] Farber B.,A. Wolff. Salicylic acid prevents the adherence of bacteria and yeast to silastic catheters. Journal of biomedical materials research, 1993. 27(5)599-602.
[288] Li F., X. Zhou, H. Mao. A study of paeonol injection on immune functions in rats.中国中西医结合杂志.1994,14(1): 37-42.